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Abstract 
Muscles are responsible for the movement of body and take up roughly half of the 
person’s body weight. Skeletal muscles are the only voluntary muscle tissue in human 
body, being controlled consciously.  
Skeletal muscle cells form when many smaller progenitor cells lump themselves together 
to constitute long, straight, multinucleated fibers. The proliferating muscle cells are called 
myoblasts. Myoblasts fuse together to form multinucleated non-proliferating cells called 
myotubes. The transition from proliferative to differentiated state involves a complete 
shift of the cell’s transcriptome based on a network of regulation at the molecular level. 
To uncover the intricacies of molecular activities involved in the process of muscle 
differentiation it is essential to have deeper and through understanding of the 
transcriptome in its entirety. RNA seq, which is a high through put sequencing 
technology, gives us the opportunity to reach into the deepest level of the transcriptome.  
By means of the RNA seq technology I obtained the in-depth view of the transcriptome of 
human muscle cells from the proliferative to the differentiated stage. The analysis was 
extended also to small RNAs, to have a full picture of the transcriptome. I performed the 
analysis with the specific objectives of identifying the expressed genes and finding out 
differential gene expression, of both mRNA and miRNA. I also investigated the crosstalk 
between mRNA and miRNA, employing two separate methods : miRNA over expression 
and Ago2  immunoprecipitation followed by RNA seq.  
The over expression experiments were carried out with 5 different miRNAs and in all 
cases I found more genes turned up than turned down.  These results suggest that miRNA 
might either have a role in mRNA stabilization or it could play a part in a double negative 
mechanism by inhibiting some negative factor. By comparing the genes down regulated 
after miRNA over expression with Ago2-enriched genes we have found several candidate 
genes which are most likely under the down regulatory control of miRNA.   
Skeletal muscle has enormous plasticity and can endure a lot of stress. To study this 
aspect of muscle we performed mechanical stretch of differentiating muscle cells. With 
RNA seq we got the in-depth view of the transcriptome as a response to stretch. We 
performed the analysis at two time points after stretch and found that stretch triggered 
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immune response genes soon after, but enhanced muscle structural-protein genes 
expression over a prolonged course of time when the immune response takes a back seat.  
I believe that our thorough transcriptome analysis, including miRNA and mRNA 
interaction studies during myogenesis, contributes towards the better understanding of the 
process regulating muscle development.  
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Riassunto 
I muscoli sono responsabili dei movimenti del corpo e costituiscono circa metà del peso 
di una persona. I muscoli scheletrici sono i soli tessuti muscolari volontari, essendo 
controllati coscientemente. 
Le cellule del muscolo scheletrico si formano quando diverse piccole cellule progenitrici 
si conglobano tra loro per formare lunghe affusolate fibre multinucleate. Le cellule 
muscolari proliferanti sono chiamate mioblasti. I mioblasti si fondono tra loro per formare 
cellule multinucleate e non proliferanti, chiamate miotubi. La transizione dallo stato 
proliferante a quello differenziato implica un completo cambiamento del trascrittoma 
cellulare, basato su una rete di regolazione a livello molecolare. Per scoprire il groviglio 
di attività molecolari implicate nel processo di differenziamento muscolare è essenziale 
avere una più profonda ed estesa comprensione del transcrittoma nella sua interezza. 
L'RNA seq è una  tecnologia di sequenziamento massivo che ci offre l'opportunità di 
accedere ai livelli più approfonditi del trascrittoma.      
Con la tecnologia dell'RNA seq ho ottenuto una precisa visione del trascrittoma delle 
cellule muscolari umane, sia allo stadio proliferativo che a quello differenziato. Per avere 
una visione completa del trascrittoma, l'analisi è stata estesa anche agli small RNA. Ho 
svolto queste analisi con l'obiettivo specifico di identificare i geni espressi e di 
evidenziare in particolare quelli differenzialmente espressi, sia per quanto riguarda gli 
mRNA che i miRNA. Ho anche analizzato il crosstalk tra mRNA e miRNA, impiegando 
due diversi metodi: sovraespressione dei miRNA e immunoprecipitazione di Ago2, 
seguita da RNA seq. 
Gli esperimenti di sovraespressione sono stati condotti con 5 diversi miRNA e in tutti i 
casi ho trovato più geni che hanno aumentato il loro livello piuttosto di geni che l'hanno 
diminuito. Questi risultati suggeriscono che i miRNA potrebbero avere un ruolo nella 
stabilizzazione degli mRNA, oppure potrebbero avere un ruolo in un doppio meccanismo 
negativo, inibendo a loro volta fattori negativi. Confrontando i geni che diminuiscono di 
livello dopo la sovraespressione di miRNA con i geni arricchiti 
dall'immunoprecipitazione con Ago2, abbiamo trovato diversi geni candidati per essere 
sotto il controllo inibitorio dei miRNA. 
Il muscolo scheletrico ha una grande plasticità e può sopportare un notevole stress. Per 
studiare questo aspetto del muscolo abbiamo sottoposto le cellule in differenziamento a 
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stiramento meccanico. Con l'RNA seq abbiamo ottenuto un'approfondita visione del 
trascrittoma in risposta allo stiramento. Abbiamo effettuato queste analisi a due diversi 
tempi dopo lo stiramento ed abbiamo trovato che nel periodo immediatamente successivo 
allo stimolo vengono sovraespressi geni implicati nella risposta immunitaria, mentre 
successivamente sono attivati i geni codificanti proteine muscolari strutturali, quando allo 
stesso tempo la risposta immunitaria viene inibita. 
Sono convinta che la nostra approfondita analisi del trascrittoma che include l'interazione 
di mRNA e miRNA durante la miogenesi, possa contribuire ad una maggiore 
comprensione di processi che regolano lo sviluppo muscolare. 
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Chapter 1 
Introduction 
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1.1 Skeletal muscle  
Skeletal muscle is one of the most highly organised structures in the biological world, and 
is primarily involved in the execution of voluntary movement (1). Skeletal muscle is 
composed of a number of muscle fibre types that differ with respect to their contractile, 
metabolic and molecular properties (2). The characteristics of a skeletal muscle is its 
contractile function  
1.1.1 – Structure  
Skeletal muscle is composed of many individual muscle fibres (3). Each fibre is covered 
in endomysium and beneath this, resides the cell membrane or sarcolemma. Structurally, 
each muscle fibre is composed of many protein bundles called myofibrils, which in turn 
comprise of alternate dark and light staining filaments (3). The sarcomere is composed of 
the thin (actin) filaments, the thick (mostly myosin) filaments, and the giant filamentous 
molecule titin.  Titin alos known as connectin is the molecular spring that is responsible 
for the passive elasticity of the muscle. It connects the Z line to the M line in the 
sarcomere. The thin filaments are anchored in the Z-line, where they are cross-linked by 
α-actinin. The thick filament is located centrally in the sarcomere and constitutes the 
sarcomeric A-band. The myosin heads, interact with actin during activation. In the A-
band titin is inextensible due to its strong interaction with the thick filament. The distance 
from one Z-line to the next is defined as one sarcomere, the smallest integral contractile 
unit (1). 
1.1.2 Myogenesis 
The formation of skeletal muscle involves a series of steps in which multipotential 
mesodermal precursor cells become committed to a muscle cell fate and then proliferate 
as myoblasts until they encounter an environment lacking mitogens, at which point they 
exit the cell cycle and differentiate (4). Skeletal, cardiac, and smooth muscle are each 
derived from mesodermal precursor cells in different regions of the embryo. Although 
these three different muscle cell types express many of the same muscle-specific genes, 
each type is unique with respect to the spectrum of muscle genes they express, their 
morphology, their ability to divide, and their contractile properties. Therefore, if any 
shared myogenic program exists it must be modified by different regulatory factors to 
generate the diversity of three muscle cell types. 
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Adult myogenic cells are derived mainly from muscle satellite cells that are specialized 
myogenic cells found during late fetal development. In mice the myogenic precursors in 
the dermomyotome express Pax3, Pax7 and low levels of the myogenic determination 
factor Myf5. The paired-domain transcription factors Pax3 and Pax7 act upstream of the 
primary myogenic basic helix–loop–helix (bHLH) transcription factors Myf5 and MyoD, 
in myogenic specification. When myogenic determination genes MyoD and Myf-5 are 
activated the muscle precursor cells are committed to become myoblasts and migrate into 
the adjacent embryonic connective tissue, or mesenchyme and express other muscle 
specific genes such as myogenin and MRF4, that after a period of proliferation, induce 
the fusion of myoblasts into multinucleated and highly specialized skeletal muscle cells 
called myotubes or myofibres (5). A typical myofibre is cylindrical, large (measuring 1-
40 mm in length and 10-50 μm) and multinucleated (containing as many as 100 nuclei). 
Muscle fiber is a cylindrical multinucleate cell composed of numerous myofibrils that 
contracts when stimulated. Muscle fibres are the basic contractile units of skeletal muscle 
and are individually surrounded by a layer of connective tissue and grouped into bundles to 
form skeletal muscle (6, 7). 
1.1.3 Differentiation 
Skeletal muscle development involves an initial period of myoblast replication followed by a 
phase where some myoblasts continue to proliferate while other undergoes terminal 
differentiation. The process of differentiation involves permanent cessation of DNA 
synthesis, activation of muscle specific gene function and fusion of single cells into multi 
nucleated muscle fibers (51).   Skeletal muscle differentiation is a tightly regulated process 
that requires the coupling of muscle-specific gene expression with the terminal withdrawal 
from the cell cycle. The MyoD family of basic helix-loop-helix (bHLH) skeletal muscle 
specific transcription factors plays a pivotal role in initiating skeletal muscle differentiation. 
MyoD and Myf-5 are the most important members of this protein family and are 
expressed in proliferating and undifferentiated cells, whereas the expression of other 
bHLH transcription factors such as myogenin and MRF-4 occurs only during 
differentiation or in adult mature skeletal muscle, respectively. These four myogenic 
bHLH proteins are known as myogenic regulatory factors (MRFs). The MRFs are able to 
bind DNA both in the form of homodimers as well as in the form of heterodimers with 
ubiquitously expressed transcription factors called E proteins. Their binding sites, called 
E boxes, share the consensus sequence CANNTG. The binding of the bHLH/E protein to 
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DNA is essential for the activation of the muscle specific differentiation program (8). The 
differentiation process starts during embryogenesis, when the appropriate environmental 
stimuli are encountered. In the myotome of the embryo, the MRF’s present in determined 
myoblasts (MyoD and Myf-5) initiate a cascade of events that leads to the activation of 
other transcription factors, the MEF2 family, which are necessary for the transcription of 
myogenin and other skeletal muscle specific genes. Myogenin itself can also activate 
MEF2, creating a positive regulatory loop that ensures the maintenance of appropriate 
levels of these proteins in differentiating skeletal muscle (8, 9). Amongst the earliest 
muscle genes to be expressed in the myotome are desmin, Titin and α-actin. The 
expression of the myosin heavy chain gene occurs almost a day after the accumulation of 
the α-actin protein. Committed myoblasts initiate their transformation into differentiated 
myotubes by first expressing all the major structural proteins. Then, the other muscle 
genes are activated following a strict temporal regulation during the embryonic, fetal and 
postnatal development (10). At the same time a system intervenes to allow the cell to exit 
from the cell cycle thus permitting tissue specific gene expression, cell fusion and the 
formation of multinucleated myotubes (8). These events involve both muscle specific 
transcription factors and ubiquitous cell cycle regulatory proteins. In fact MyoD, that 
represents the major coordinator of skeletal muscle differentiation, is also able to induce 
the expression of p21, a potent inhibitor of Cyclin-Dependent Kinases (Cdks), thus forces 
the cell cycle withdrawal (11). This event inhibits the Retinoblatoma protein (pRb) 
phosphorylation thus promoting its activation and allowing it to sequester the E2F 
transcription factor, thus blocking cell cycle progression (12). Moreover MyoD and pRb 
can directly interact with each other (13). 
Many other cell cycle regulatory proteins are involved in this complex picture. In fact the 
p53 tumor suppressor protein is essential in the process of skeletal muscle differentiation, 
since p53-impaired cells fail to differentiate (14, 15) even though cell cycle withdrawal 
takes place in a p53-independent manner. Indeed the p53 tumor suppressor is crucial to 
elevate un-phosphorylated pRb levels to a threshold sufficient to terminally maintain the 
cell in G0/G1 (17) and to activate together with MyoD the expression of late muscle 
differentiation markers (18, 19). The last step in the differentiation process is represented 
by myoblasts fusion. This event correlates with fibronectin secretion onto the 
extracellular matrix, to which differentiating cells attach using the α5β1 integrin. After 
that, myoblasts start aligning. This step is mediated by several cell membrane 
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glycoproteins, including several cadherins and CAMs. Ultimately cell fusion occurs, 
mainly through the action of a set of metalloproteinases called meltrins and 
multinucleated differentiated myofibres are formed (20). 
 
1.1.4 Skeletal muscle contraction  
Muscle contraction consists of a cyclical interaction between myosin and actin driven by 
the concomitant hydrolysis of adenosine triphosphate (ATP) (21). Myosin and actin, the 
components which respectively form the thick and thin filaments were amongst the first 
proteins to be purified with reference to muscle function (22). The hexametric protein 
myosin comprises two heavy chains (220 KDa) and four light chains (20-25 KDa), and 
forms the thick filaments. The terminus of myosin forms a globular head region required 
for the hydrolysis of ATP and binding of actin. The four light myosin chains are located 
between the globular head and the carboxy-terminal rod region (1). Thin muscle filaments 
are comprised of several proteins; however actin (43 KDa) is by far the most abundant 
constituent. Thick and thin regions of physical overlap form in which globular myosin 
heads project from the thick filaments to interact with thin actin filaments. ATP 
hydrolysis mediates a conformational change in the globular myosin heavy chain head 
region, resulting in an interaction between the globular head and actin further along the 
filament and inducing a shortening of the muscle fibre. 
Multiple isoforms of myosin heavy chain (MHC) exist, which comprise a family of 
molecular motors able to modulate the speed of skeletal muscle contraction (23). The 
contractile speed of a particular muscle fibre may therefore be determined, in part, by the 
isoform of MHC protein which it expresses. The sarcomeric MHC family consists of at 
least eight known isoforms, each encoded by a distinct gene located in two multigenic 
regions on two separate chromosomes (24). Six genes are encoded by a 300 – 600Kb 
segment on human and mouse chromosomes 17 and 11 respectively, in a cluster 
arrangement in the order MyH3/MyH2, MyH1/MyH 4, MyH 8/ MyH13 (5’ – 3’). The 
MyH2, MyH1 and MyH4 genes encode the protein isoforms commonly termed MHC 
IIA, IIX and IIB. Of the eight sarcomeric isoform genes of MHC, four are known to be 
expressed in adult skeletal muscle: one “slow-twitch” (Type I) muscle associated MHC 
isoform is encoded by the MyH7β gene and three “fast-twitch” (Types IIA, IIX and IIB) 
muscle associated isoforms, associated with increasing contractile speed. A combination 
11 
 
of the latter “fast-twitch” isoforms account for over 90% of MHC in adult skeletal muscle 
(25).  
1.1.5 Skeletal muscle metabolism  
Muscle contraction is driven by the hydrolysis of adenosine triphosphate (ATP) (21) 
which may be derived from the metabolism of fatty acids (β-oxidation) or carbohydrates 
(glycolysis). The β-oxidation of fatty acids takes place in the mitochondria of muscle 
fibres. Endothelial lipoprotein lipase (LPL) is involved in the transport of fatty acids from 
the circulatory system into the myocellular compartment (26). Hormone sensitive lipase 
(HSL) liberates free fatty acids from the intramyocellular lipid (IMCL) pool which are 
transported into the mitochondrion for β-oxidation by carnitine palmitoyltransferase 1 
(CPT-1). The production of ATP via the β-oxidation of fatty acids is an oxygen-
dependent process. 
Carbohydrates reach the myofibre from the circulatory system and may be stored as 
glycogen, converted to triglycerides, or metabolised via glycolysis. In contrast to β-
oxidation, the metabolism of carbohydrates via glycolysis is an oxygen independent 
process; however metabolism under these conditions leads to the production of lactate 
(26). 
1.2miRNA and its role in general 
A microRNA is a small non-coding RNA molecule (22 nucleotides) found in plants, 
animals, and some viruses, which functions in transcriptional ans post-transcriptional 
regulation of gene expression. Encoded by nuclear DNA in plants and animals and by 
viral DNA in certain viruses whose genome is based on DNA, miRNAs function via base 
pairing with complementary sequences within mRNA molecules, usually resulting in 
gene silencing via translational repression or target degradation. The human genome may 
encode over 1000 miRNAs, which may target about 60% of mammalian genes and are 
abundant in many human cell types. 
1.2.2 miRNA biogenesis 
miRNAs are transcribed into long transcripts mainly by RNA polymerase II, although 
there are also evidences implicating RNA polymerase III in the transcription of some 
miRNAs (27). Most of them are polyadenylated in its 3’end and capped at its 5’extremity, 
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like mRNAs. In the canonical pathway (Fig 10) these primary-miRNAs (pri-miRNAs) 
folds into a stem loop structure that will be further processed by two RNAse III 
endonuclease, Drosha and Dicer. In the nucleus, the hairpin structure is cleaved from the 
flanking regions originating the precursor-miRNA (pre-miRNA) that is ≈70 nucleotide 
long. This first processing step is catalyzed by Drosha that is helped by a cofactor, 
DGCR8 (DiGeorge syndrome critical region gene 8) (Pasha in Drosophila). This complex 
is called the Microprocessor. DGCR8 contains two dsRNA-binding domains that directly 
interact with the stem-loop and with the flanking region, serving as a molecular anchor to 
Drosha that carries out the cleavage reaction. The cleavage produces highly exact 
extremities and is highly regulated. The production of pre-miRNAs not always requires 
the participation of the microprocessor complex. In fact, a rare alternative pathway has 
been identified initially in fly and nematodes, but also present in mammals (28, 29, 30). 
This pathway uses the splicing machinery to liberate introns that mimic the features of 
pre-miRNAs. These structures are called mirtrons. After being spliced they enter the 
normal miRNA processing pathway. 
Pre-miRNAs are then exported to the cytoplasm by Exportin-5 in a Ran-GTP dependent 
way, where they will be further processed. In the cytoplasm the terminal loop of the pre-
miRNA is cleaved originating a mature dsRNA of approximately 22 nucleotides of 
length. This step is carried out by Dicer. The PAZ domain of Dicer binds to the 
3’overhangs of the pre-miRNAs and this binding determines the cleavage site since that 
Dicer’s catalytic sites are located precisely two helical turns away from the PAZ domain 
(bound to the pre-miRNA). In this step, Dicer is assisted by the Tar RNA Binding Protein 
– TRBP (know as Loquacious in Drosophila), another dsRNA binding protein. At the end 
of this last processing step Argonaute 2 is recruited to the complex Dicer/TRBP leading 
to the unwinding of the duplex. At this stage one of the strands, the mature miRNA, is 
preferentially incorporated into the complex that will repress target gene expression – the 
RNA-Induced Silencing Complex (RISC). The choice of the mature strand is based on the 
thermodynamic stability of the two ends of the duplex. The complementary strand 
(miRNA*) in most cases is degraded. However there are growing evidences that both 
strands can be incorporated into the RISC complex in a functional way (31). 
The key proteins of the RISC complex are the Argonautes (AGO). These proteins contain 
three highly conserved domains, PAZ, MID and PIWI domains, that interact with the 
miRNAs. In mammals there are four AGO that function in miRNA repression (Ago1 to 
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Ago4). Different AGO proteins seems to have different specificity to the miRNA or 
siRNA pathway. Another crucial factor for miRNA-repression is the GW182 protein. 
This protein interact directly with AGO proteins and are thought to be the effectors of 
AGO. There are other proteins interacting with RISC to modulate miRNA function. This 
is the case of Fragile X Mental Retardation Protein (FMRP), which binds RNA molecules 
and might modulate translation. Also RNA Helicase RCK/p54, which is a p-body 
component, is thought to be essential to induce repression. Finally TRIM32 was recently 
seen to bind the RISC components enhancing in this way its activity. However further 
studies are required for a better understanding of the proteins that modulate this complex 
process of miRNA-mediated repression (32, 33, 34). 
1.2.3 mRNA degradation 
There are two mechanism for mRNA degradation, the first being when mRNAs undergo 
endolytic cleavage by Ago2 (37) and the second is when mRNAs undergo poly(A) 
removal by deadenylases (38). 
1.2.4 Translational activation 
Some studies indicate that miRNAs can stimulate translation under specific conditions. 
Two proteins are important for this ability of miRNAs to activate growth arrested 
mammalian cells. One is Ago2, the other one is FXR1, an RNA binding protein 
homologus to fragile X mental retardation protein FMR1/ FMRP. Surprisingly it was 
found that human Ago2 activates translation of target mRNAs on cell cycle arrest caused 
by serum starvation or contact inhibition, while it normally repressed translation of same 
target mRNAs in proliferating cells. FXR1 associates with Ago2 and helps to mediate the 
positive influence of miRNAs on translation (35, 36). Like translational repression, such 
activation requires base pairing between mRNA and seed region of miRNA. 
1.3 miRNA target prediction  
One of the most critical part in the study of miRNAs is the identification of the target 
genes they regulate. The study of the molecular mechanism implicated in target 
recognition, together with computational approaches were soon translated into basic 
principles used in the development of bioinformatic tools that could predict miRNAs 
targets. 
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The majority of animal miRNAs displays only modest base-pairing to their targets in 
contrast to what happens in plants, where the base pairing is perfect. Historically, 
miRNAs are known to regulate the 3’UTR of the target genes. This was experimentally 
demonstrated with the first miRNAs identified and it was also assumed as an in silico 
convenience that was further confirmed experimentally. But the use of these predictive 
algorithms has left underestimated the possibility that miRNAs might regulate other 
regions, such as the 5’UTR or even the coding region of the mRNAs. In fact, experiments 
involving artificial and natural mRNAs have shown that their 5’UTR can be targeted by 
miRNAs (39). Recent reports have also started to address the possibility that miRNAs can 
target the Open Reading Frame (ORF) of certain genes.  
The interaction between miRNA and mRNA are through base pairing - most of the times 
imperfect base pairing. The most important region of the miRNA is the so called “seed” 
region. According to the seed “rule”, the interaction between miRNA and mRNA requires 
a contiguous and perfect (or nearly perfect) Watson-Crick base pairing of the 5’ 
nucleotides 2-8 of the miRNA. Another point to take into consideration when discussing 
the miRNA/mRNA interaction is the presence of multiple sites in the same 3’UTR. In 
fact this seems to lead to a more efficient mRNA repression. Some algorithms also take 
into account the conservation between related species of the miRNA-binding site. Finally 
one must consider that mRNAs have a secondary structure that might block miRNAs 
binding (40, 41, 42). 
Giving different weight to each of these parameters, several algorithms were developed to 
predict miRNAs targets. The most known and robust ones are: TargetScan, PicTar, 
Miranda and PITA. 
Although the principles used for target recognition are quite well established and 
accepted, and considering that different algorithms have different sensibilities, validation 
of the predicted targets is always required. 
 
1.4 miRNA in skeletal muscle tissue 
One of the first evidences that miRNAs might play a crucial role in adult skeletal muscle 
came from a study in sheep (43). The aim of the study was identifying the gene 
responsible for the hypertrophic phenotype of the Texel sheep. The authors found a point 
mutation in the 3’UTR of the myostatin gene that creates a new binding site for the 
miRNA-1 and miRNA-206. In these breed of animals, myostatin, a negative regulator of 
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muscle growth, is down-regulated by these two muscle-specific miRNAs inducing an 
exacerbated muscle growth. 
Important evidence highlighting the essential role that miRNAs play in muscle came from 
loss-of-function experiments. In this case, O’Rourke et al (44), generated a muscle 
specific conditional knock-out of Dicer, the RNAse III enzyme required for miRNA 
maturation. In these mice, the expression of Cre recombinase was under the control of 
MyoD regulatory elements, and therefore started to be expressed from embryonic day 9.5. 
All Dicer skeletal muscle mutants died just after birth. They showed severe defects in 
skeletal muscle embryonic development that was mainly translated in muscle hypoplasia 
with hypertrophy of the few remaining fibers. This hypoplasia was attributed to an 
increase apoptosis rather than a defect in myofibers formation. These results are similar to 
the ones obtained by (45, 46) in which the knock-down of the muscle specific miRNA-1 
in Drosophila caused arrest in embryogenesis with disorganized muscle development and 
aberrant expression of muscle-specific genes. Altogether these results anticipate a 
fundamental role of miRNAs in different aspects of skeletal muscle biology.  
 
1.5 RNA seq and Transcriptome analysis 
The transcriptome is the set of all RNA molecules, including mRNA, rRNA, tRNA, and 
other noncoding RNA produced in one or a population of cells. In multicellular 
organisms, nearly every cell contains the same genome and thus the same genes. 
However, not every gene is transcriptionally active in every cell. Different cells show 
different patterns of gene expression. These variations underlie the wide range of 
physical, biochemical, and developmental differences seen among various cells and 
tissues and may play a role in the difference between health and disease. Thus, by 
collecting and comparing transcriptomes of different types of cells or tissues, researchers 
can gain a deeper understanding of what constitutes a specific cell type and how changes 
in transcriptional activity may reflect or contribute to disease. RNA-seq is a new method 
in RNA sequencing to study mRNA expression. By considering the transcriptome, it is 
possible to generate a comprehensive picture of what genes are active at various stages of 
development. Not until a decade back the enormous complexity of human genome has 
been realized (47). Transcritome analysis has traditionally focused on cytoplasmic 
poly(A)+ RNA, which excluded non coding part of the genome (eg, tRNA, linc RNA, 
miRNA , siRNA) and hence a very large segment of important information remained 
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inadequately considered. But now that the non coding part of the genome is emerging as 
the most important regulatory population of the cell, advanced technique oriented towards 
delving deeper inside the transcriptome with better sensitivity to trace minor changes in 
gene expression and for discovering new transcripts. 
Next generation sequencing provides the way for the much sought after need of 
understanding the complexity of transcriptome.  With a dynamic range to detect subtle 
changes in expression level in a hypothesis-neutral environment, next generation 
sequencing helps provide an understanding of biological response to stimuli or 
environmental changes. The potential of RNA seq technology for studying transcriptome 
has been described by Wang et al (48). The application of RNA seq technology is vast 
from finding differential gene and transcript expression to revealing unannotated 
transcripts (49, 50).  
 
1.6Outline of the thesis      
In the present thesis, full transcriptome analysis of human skeletal muscle during 
development, through proliferation to differentiation has been presented in four chapters.  
Chapter 2 deals with the entire transcriptome sequence of human myoblast and myotube 
cells along with adult skeletal muscle tissue. The transcriptome analysis includes 
miRnome sequencing also. Entire list of differentially expressed genes has been 
presented. miRNA candidates have also been found. Genes of specific protein families 
with substantial expression has been shown. To understand the biological meaning of the 
genes, GO and pathway analysis results have been presented. Argonaute 2 
immunoprecipitation has been performed to capture the genes bound to Ago2 and hence 
supposedly bound to the RISC complex,that gave us the probable candidate genes under 
miRNA repressing action. 
In Chapter 3 differentially upregulated miRNA in myotubes presented in chapter 1 have 
been analyzed for their functional role. Genes enriched with Ago2 IP (chapter 1) were 
used for the analysis of target recognition of the miRNA.  
Chapter 4 shows the transcriptome behaviour of myotubes differentiated under 3D culture 
conditions and their similarity and difference in comparison with muscle tissue and 2D 
culture has also been presented. 
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In Chapter 5 The response to mechanical stretch of differentiating muscle cells have been 
presented. Prompt response and delayed response of the transcriptome to mechanical 
stretch has been studied and presented in this chapter. 
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Chapter - 2 
 
Myoblast, myotube and skeletal 
muscle transcriptome, miRnome 
dynamics and functional profiling  
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2.1 Introduction: 
Understanding the dynamics of muscle transcriptome during muscle growth and 
development is necessary to uncover the complex mechanisms underlying muscle 
development. The formation of skeletal muscle during vertebrate embryogenesis requires 
commitment of mesodermal precursor cells to skeletal muscle lineage, withdrawal of 
myoblasts from cell cycle and transcriptional activation of dozens of muscle structural 
genes. MyoD, myogenin, Myf5 and MRF4 act to establish myoblast identity and to 
control terminal differentiation. Myogenic bHLH factors interact with components of the 
cell cycle machinery to control withdrawal from the cell cycle and act combinatorial with 
other transcription factors to induce skeletal muscle transcription. Elucidation of these 
aspects of the myogenic program is leading to a detailed understanding of the regulatory 
circuits controlling muscle development. Skeletal muscle differentiation entails the 
coupling of muscle-specific gene expression to terminal withdrawal from the cell cycle. 
Several models have recently been proposed which attempt to explain how regulated 
expression and function of myogenic transcription factors ensures that proliferation and 
differentiation of skeletal muscle cells are mutually exclusive processes. 
Skeletal muscle is the dominant organ system in locomotion and energy metabolism. 
Postnatal muscle grows and adapts largely by remodelling pre-existing fibres, whereas 
embryonic muscle grows by the proliferation of myogenic cells.  
The role of miRNA in muscle development is widely acknowledged now. Many groups 
of researchers have shown the important regulatory roles miRNA play during muscle 
development. miR-145 and 143 are known to regulate smooth muscle plasticity (7). Sun 
et al have shown the involvement of miR-24 in skeletal muscle differentiation (8). miR-
181 has been shown to target Hox-A11 during myoblast differentiation (9). miR-1, miR-
133 and miR-206 are skeletal muscle specific miRNA and have been extensively studied 
by many researchers (10, 11, 12).  
To understand the complicated molecular networks working behind muscle development 
we need to obtain a thorough knowledge of the transcriptome first before the interactive 
networks are unravelled. We have attempted to do so by carrying out transcriptome 
sequencing at a massive scale. We performed the experiments in replica to have more 
reliable results.    
The advent of next generation sequencing technology gives us the opportunity of 
capturing the full transcriptomic panorama of a cell at a given point of time. We used 
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NGS technology to our advantage and performed RNA seq of proliferating and 
differentiating primary human muscle cells along with adult human skeletal tissue. The 
functional significance of the genes differentially expressed from one developmental 
stage to next was studied by using Gene Ontology and pathway analyses. We also 
evaluated miR transcriptome profiles during the proliferative and differentiating stages of 
primary human muscle development.  Since muscle cells ultimately grow into skeletal 
tissue we considered that it was worth to study the miRNA profile of adult human skeletal 
muscle tissue also, to understand how the miRNA population modulates itself from the 
cellular level to the tissue which is the ultimate functional form in the body. We were also 
interested in understanding the regulatory roles played by miRNAs. But we wanted to do 
it independent of any prediction algorithms as there are biases in prediction and also a 
huge number of false positives. So, we performed Ago2-RIP (Argonaute 2 RNA 
immunoprecipitation) experiments to capture the mRNA population that is associated 
with Ago-2 protein. Since Ago2 is a component of RISC complex which carries the 
miRNA and eventually chops off the mRNA or inhibits its translation, the mRNA 
associated with Ago2 most likely presents the population which is controlled by miRNA. 
We did the RNA seq of the immunoprecipitates and performed differential expression 
analysis in comparison with non Ago2 pull down RNA population. The Ago2 RIP was 
performed for myoblasts and myotubes. The mRNA population enriched with Ago2 was 
compared with mRNA differentially down regulated in myoblasts and myotubes.  We did 
this to find out the population of genes repressed. The genes found in common were 
subjected to GO analyses and we saw interesting results from the analyses. The schematic 
representation of the experimental design is shown below:         
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Schematic representation of experimental plan. All the RNA seq, miRNA seq and 
Ago2 pull downs were performed in replica. Arrows in green show the comparison of 
genes enriched in Ago2 pull down versus genes down regulated. The genes found 
common from the comparison are most likely repressed by miRNA.  
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2.2 Materials and methods: 
2.2.1 Cell Culture (Human primary skeletal muscle cells (CHQ5B)):  
CHQ5B primary human myoblasts were kindly provided by Dr. V. Mouly (URA, CNRS, 
Paris, France) (24). CHQ5B human myoblasts were isolated from the quadriceps of a 
newborn (5 days post-natal) without any sign of neuromuscular disorders and the 
protocols used for this work were in full agreement with the current legislation on ethical 
rules. This strain of cells can achieve 55-60 divisions before reaching proliferative 
senescence. 
Growth conditions: DMEM (Gibco - Invitrogen) supplemented with 20% Fetal Bovine 
Serum (Gibco, Life Technologies) and 50µg/ml gentamycin.  
Differentiation conditions: DMEM supplemented with 2% horse serum (GibcoBRL) and 
50µg/ml gentamycin.  
Differentiation of myoblasts into myotubes has to be induced by serum withdrawal 
without letting the myoblast culture reach confluency, as that reduces the myoblast 
population in the culture. Myotube formation can be observed after two days since serum 
withdrawal.  
2.2.2 RNA extraction from cells: 
2.2.2.1. a Poly (A) extraction from cells: 
Polyadenylated RNA was extracted directly from cells using QuickPrep micro mRNA 
purification kit (Amersham Biosciences). Cells were scrape collected after PBS washing, 
snap frozen in dry ice and stored at -80°C until use. 400µl extraction buffer (buffered 
aqueous solution containing guanidium thiocyanate and N-lauroyl sarcosine) was added 
to the pelleted cells and vortexed until homogenous suspension was achieved. This 
suspension was diluted with 800 µl of elution buffer (10mM Tris HCl, pH 7.5, 1mM 
EDTA) and mixed using the vortex. The mixture was centrifuged at 12,000g for 1 minute 
and the clear cellular homogenate was added to the Oligo(dT) beads (25mg/ml oligo dT 
cellulose suspended in buffer) pellet. Cellular homogenate and oligo (dT) beads were 
incubated together for 5 minutes at 70 -75 °C. This causes the denaturation of RNA and 
enhances the binding of poly (A) tail of RNA with the oligo dT beads. The sample was 
incubated at room temperature for 30 minutes with gentle agitation. Supernatant was 
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removed by centrifugation at 12,000g for 30 seconds. The oligo (dT) cellulose pellet was 
washed 4 times using high salt buffer (10mM TrisHCl, pH 7.5, 1mM EDTA, 0.5M NaCl) 
followed by washing with low salt buffer (10mM TrisHCl, pH 7.5, 1mM EDTA, 0.1M 
NaCl) for another 4 times. High salt conditions allow the annealing the poly(A) tail to the 
oligo d(T). The low salf buffer removes the poly(A)- RNAs (eg. tRNA and rRNA). These 
washings remove contaminating DNA, RNA proteins. The oligo dT beads were 
transferred to the microspin column (polypropylene minicolumns) and suspended in pre 
heated 100 -200 µl elution buffer (10mM Tris HCl, pH 7.5, 1mM EDTA) or pre heated 
RNase free water (Sigma) which releases the poly(A)
+
 RNA and the tube was centrifuged 
at 12,000g for 30 seconds. The eluate contained poly (A) RNA which was stored at -80°C 
until downstream processing. 
 
2.2.2.1. b Poly (A) enrichment from total RNA: 
Poly(A) was enriched from total RNA preparations using Dynabeads mRNA direct kit 
which relies on the pairing between the poly(A)tail of mRNa and the oligo dT sequence 
linked to the surface of the beads. Dynabeads oligo (dT)25 are uniform, 2.8 µm diameter, 
superparamagnetic, polystyrene beads with 25 nucleotide long chains of 
oligodeoxythymidine covalently attached to the bead surface via a 5’ linker group.  RNA 
extraction was performed accoding to manufacturer’s instructions. The resultant mRNA 
was quantified using nanodrop and Qubit fluorometer. Quality assessment was performed 
with agilent bioanalyzer.   
 
2.2.2.2 Extraction of total ribonucleic acids (Total RNA): 
Prior to extraction, all glassware was autoclaved to ensure sterility and inactivation of 
contaminating proteins such as nucleases. When possible, sterile plastic was used instead 
of glassware. To minimize the loss of nucleic acis, DNA Lobind molecular biology grade 
1.5 ml tubes (Eppendorf) were extensively used. Total RNA was extracted from snap-
frozen cells. 1ml TRIzol reagent (Invitrogen) was used to lyse cells grown per 10cm
2
 
dish. The lysates were incubated with TRIzol reagent at room temperature for 5 minutes 
to allow complete dissociation of nucleoprotein complexes. TRIzol is a monophasic 
solution of phenol and guanidine isothiocyanate which maintains the integrity of RNA 
while disrupting cells and dissolving cell components. 0.2 ml chloroform was used per 
1ml TRIzol reagent and tubes were shaken by hand for 15 seconds. This mixture was left 
for incubation for 2 – 3 minutes at room temperature which was followed by 
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centrifugation at 12,000g for 15 minutes at 4°C. Addition of chloroform followed by 
centrifugation separates the solution into aqueous phase and organic phase. RNA remains 
exclusively in the aqueous phase. The colorless upper aqueous phase containing the RNA 
is then transferred to a new 1.5 ml tube. An equal volume of 70% ethanol is added to the 
aqueous phase to obtain a final ethanol concentration of 35% and this mixture is mixed 
well by vortexing. This was followed by binding, washing and elution with the column of 
PureLink RNA mini kit (Life Technologies). Colum binding, washing and elution was 
performed according to manufacture’s instructions.   RNA was extracted either in DNase, 
RNase free water (Sigma) or Tris-EDTA buffer (10mM TrisHCl, pH = 7.5, 1mM EDTA) 
and stored at -80°C until analysis.  
 
2.2.2.3 Small RNA enrichment from total RNA: 
miRNA enrichment from total RNA sample was performed using PureLink miRNA 
isolation kit. 20 -30 µg of total RNA was used for small RNA enrichment. Total RNA 
was suspended in 90µl Nuclease free water (Sigma) to which 300µl binding buffer (L3) 
and 210µl 100% ethanol were added.  This mixture was mixed by vortexing and then 
loaded onto a spin cartridge. The spin cartridge was kept in a collection tube and spun at 
12,000g for 1 minute. The flow through was collected in a fresh 1.5ml tube. 700µl 100% 
ethanol was added to the flow through, mixed by vortexing and loaded onto another spin 
cartridge in a collection tube and spun at 12,000g for 1 minute. The flow through was 
discarded and the small RNA bound to the spin cartridge was washed twice using 500 µl 
wash buffer (W5) and by spinning at 12,000g for 1 minute.     
Small RNA was recovered by placing the cartridge in a clean recovery tube to which 50 
µl sterile, RNase free water (Sigma) was added and incubated for 1 minute. The spin 
cartridge was then spun at 16,000g for 1 minute and the eluted small RNA was stored at -
80°C. The quality assessment of the small enriched samples was performed using Agilent 
small RNA chip.     
 
2.2.3 RNA quantification and quality assessment 
2.2.3a. RNA quantification: 
The concentration of RNA was determined using both Qubit fluorometer (Invitrogen) and 
NanoDrop system (Thermo Scientific). Qubit fluorometer quantification method is based 
on fluorescence dyes that bind specifically to DNA, RNA or protein where as NanoDrop 
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quantification is based on UV absorbance measurements. Since all nucleic acids RNA, 
ssDNA, dsDNA absorb at 260 nm, they will contribute to the total absorbance of the 
sample. The degree of contamination in RNA sample preparation using NanoDrop is 
estimated by A260/A280 and A260/A230 ratio. A260/A280 ratio of ~2.0 is generally accepted as 
“pure” for RNA. If the ratio is appreciably lower, it may indicate the presence of protein, 
phenol or other contaminants that absorb strongly at or near 280 nm. A260/A230 ratio is a 
secondary measure of nucleic acid purity. The 260/230 values for “pure” nucleic acid are 
often higher than the respective 260/280 values. Expected 260/230 values are commonly 
in the range of 2.0-2.2. If the ratio is appreciably lower than expected, it may indicate the 
presence of contaminants which absorb at 230 nm. 
However, NanoDrop suffers a drawback. UV absorbance readings indiscriminately 
measure anything that absorbs at 260 nm, including DNA, RNA, protein, degraded 
nucleic acids, and free nucleotides. Whereas, the Qubit® Quantitation Platform, in 
contrast, utilizes specifically designed fluorometric technology using Molecular Probes® 
dyes to measure the concentration of the specific molecules of interest. These fluorescent 
dyes emit signals only when bound to specific target molecules, even in the presence of 
free nucleotides or degraded nucleic acids. Samples were prepared for RNA assay 
following manufacturer’s instructions. Fluorometric assay yielded quantification of 
nucleic acids could be compared with the data obtained using the spectrophototmeter. 
 
2.2.3b. RNA Quality assessment: 
 RNA integrity which is a critical first step in obtaining meaningful gene expression data 
was determined using Agilent bioanalyzer and RNA Nano and Pico lab chip kits (Agilent 
Technologies). The Agilent Bioanalyzer is a microfluidics-based platform for sizing, 
quantification and quality control of DNA, RNA, proteins and cells. Profiles generated on 
the Agilent bioanalyzer yield information on concentration, allow a visual inspection of 
RNA integrity, and generate ribosomal ratios. Using electrophoretic separation on 
microfabricated chips, RNA samples are separated and subsequently detected via laser 
induced fluorescence detection. The bioanalyzer software generates an electropherogram 
and gel-like image and displays results such as sample concentration and the ribosomal 
ratio. The Agilent 2100 bioanalyzer provides a better assessment of RNA intactness by 
showing a detailed picture of the size distribution of RNA fragments. The RIN (RNA 
Integrity Number) software algorithm allows for the classification of eukaryotic total 
RNA, based on a numbering system from 1 to 10, with 1 being the most degraded profile 
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and 10 being the most intact. The labels in-between are used to indicate progressing 
degradation states of the RNA sample.   
RNA samples were run either on RNA 6000 Nano or RNA 6000 Pico chips and Small 
RNA chip. Agilent small RNA chip detects RNA < 150 nucleotides long. All RNA 
samples were diluted according to the concentration range of respective chips. Following 
table gives the analytical specifications of the RNA chips. 
 
2.2.4 Cell lysate preparation: 
 
Cell lysate is a solution of cellular proteins resulting when cells are lysed (broken apart) 
under conditions which preserve the protein’s structure and function. Cell lysae 
preparation protocol is as follows: 
The culture medium was removed and cells were washed twice with cold 1X PBS, 
Thorough washing is essential as insufficient washing will contaminate lysate with media 
components (especially serum/BSA) which may erroneously elevate protein 
concentration. All PBS was removed completely to prevent unwanted dilution of the final 
product.  Cells were detached into 10 ml cold PBS with rubber policeman and the cell 
suspension was transferred into 15ml tube. Cells were pelleted by centrifugation at 1350 
rpm for 10 minutes. Supernatant was discarded. The pellet was snap frozen in dry ice. 
Frozen cell pellets were used for cell lysate preparation. The frozen pellet of cells was 
resuspended in 300 µl lysis buffer with protease and RNase inhibitors. Resuspended 
pellet was homogenized by pipetting up and down, to break up the pellet thoroughly and 
was allowed to stand on ice for 30 minutes with intermittent vortexing every 10 minutes. 
The resulting mixture was centrifuged at 13,000g for 15 minutes at 4°C. This separates 
the debris (pellet) from total protein (supernatant). The supernatant was collected in a new 
1.5 ml tube.  
Protein concentration was measure using A-280 absorbance of Nanodrop 
(Thermoscientific).     
 
2.2.5 Protein Analysis 
2.2.5a SDS-PAGE  
Protein samples were analyzed by SDS-PAGE. Resolving gels were made at 12% of a 
37.5:1 mix of acrylamide/bis-acrylamide (Protogel) in 375 mM Tris HCl, pH 8.8, 0.1% 
v/v SDS and and 4.9 ml water. Polymerization was induced by addition of 0.1% w/v APS 
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and 15 µl TEMED. The separating gel was poured into a gel former. The stacking gel 
comprised of 4% of 37.5:1 mix of acrylamide/bis-acrylamide (Protogel) in 125mM Tris 
HCl pH 6.8, 0.2% v/v SDS and water. 0.1% w/v APS and 0.1% v/v TEMED were added 
for crosslinking. Stacking gel was poured on the top of separating gel. A gel- comb of 
corresponding thickness and desired number of wells was inserted in the stack gel and the 
assembly was left until the gel was set. Protein samples were diluted in 5X gel loading 
buffer and denatured at 95 °C for 5 minutes. Electrophoresis was carried out at 140V, 
25mA in running buffer.    
2.2.5b Western Blotting  
 
Following electrophoresis, acrylamide gels were soaked in transfer buffer. Immobilon-P 
Transfer membrane (0.45 µm), two pieces of filter paper and two pieces of sponge cut to 
the size of the gel were also soaked in transfer buffer. Immobilon-P Transfer membrane 
was soaked in methanol and water briefly before being left in transfer buffer. The PDVF 
membrane was placed on top of the pre-soaked gel and housed between two pieces of 
filter paper and sponge in the western blotting cassette of Mini Trans-Blot Electrophoretic 
Transfer Cell (Bio-Rad). The assembly was secured in a transfer tank (Mini-Protean III, 
BioRad) filled with transfer buffer, ensuring the gel-side of the assembly was orientated 
towards the cathode (and thus ensuring that proteins were transferred from the gel to the 
PDVF membrane as the current passed through the apparatus). Proteins were transferred 
to PDVF membrane at a current of 100mA for O/N. A magnetic stir-bar was placed into 
the tank and the whole apparatus placed on a magnetic stirrer at moderate speed to 
prevent the precipitation of glycine from the transfer buffer. Precipitated glycine is known 
to adhere to the nitrocellulose membrane, increasing background signal.    
Electroblotted PDVF membrane was blocked for 3 hours at RT in Bloking buffer 
(Millipore) with gentle shaking. Membrane was incubated with Anti AGO2 antibody 
(primary antibody) diluted 1:2500 in Bloking buffer (Millipore) for 3 hours with gentle 
mixing. The membrane was first washed with TBS twice for 5 minutes each wash and 
then with TBS-T for a total of 30 minutes, changing solution every 5 minutes. Following 
washing, membrane was incubated with horseradish peroxidise conjugated anti Rat 
antibody diluted 1:1000 in bloking buffer (Millipore) for 1 hour with gentle mixing. 
Following 30 minutes of washing as mentioned before, immobilized protein-antibody 
complexes were visualized by chemiluminescence using ECL plus kit (GE Healthcare) 
following manufacturer’s instructions. The membrane was exposed to photographic film 
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(Hyperfilm ECL, GE Healthcare) in a dark room, developed in developer (Kodak), rinsed 
in water and fixed in fixer (Kodak). Molecular weights of the protein bands were 
estimated by comparison with protein standards.   
 
2.2.6 Antibodies: 
Primary Antibodies: Anti Argonaute2 Rat monoclonal antibody (Sigma). 
Secondary Antibodies: Anti - rat HRP (DAKO P0450, produced in rat): Anti rat 
immunoglobulins conjugated with the horseradish peroxidase used in chemiluminescence 
detection (ECL GE Healthcare Biosciences). 
2.2.7 RNA Immunoprecipitation (RIP) 
RNA immunoprecipitation (RIP) is a very powerful procedure for the study of RNA 
binding proteins (RBPs) and their RNA targets in ribonucleoprotein (RNP) complexes. 
Antibodies raised against specific RBPs are used to coprecipitate RNPs, i.e., the RBP 
along with its RNA partner. The RNA can then be identified by next generation 
sequencing, or if testing for a specific RNA, by RT-PCR.  
RIP of AGO2 from CHQ5B myoblasts and myotubes were performed using the following 
protocol: 
Cell Lysis: Complete lysis buffer (containing protease inhibitor cocktail, RNase inhibitor 
and DTT) was added to cell pellet and incubated on ice for 30 minutes. RIP lysis reaction 
was centrifuged for 15 minutes at 13,000g at 4°C.  
 
Antibody binding to protein G sepharose: 10 µg of AGO2 antibody was prebound to 
protein G sepharose beads by overnight incubation at 4°C with constant and gentle 
rotation in a 1.5 ml tube. In order to remove excess antibody not bound to the protein G 
beads, the beads were washed using washing buffer thrice.    
 
Antigen binding to antibody: 200 ul of cell lysate was added to the precoated sepharose 
beads and incubated for 1 hour at 4°C with constant rotation. This was followed by 
washing with washing buffer.  
 
RNA extraction: Total RNA from immunoprecipitated complexes was extracted using 
Trizol and Purelink RNA Mini kit (Invitrogen).  RNA was eluted in 50 µl RNase free 
water and stored at -80°C. RNA was quantified by Nanodrop (Thermo sceintific) and 
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Qubit fluorometer (Invitrogen). The quality of RNA was assessed using Agilent 
bioanalyzer.        
 
2.2.8 Transcriptome and miRnome sequencing using Applie Biosystem’s SOLiD and 
Ion proton technology:  
 
First step of sequencing is library preparation. Whole transcriptome and small RNA 
library preparation protocol are same for both the sequencing techniques. Following is the 
description of library preparation procedure. 
 
 
 
2.2.9 Commercial RNA:            
RNA COMPANY 
Total RNA isolated from adult human skeletal muscle tissues Amsbio/ Zyagen 
Total RNA isolated from adult human skeletal muscle tissues Stratagene 
 
2.3. Results: 
To have the thorough picture of muscle transcriptomics we constructed mRNA and 
miRNA libraries for both cultured primary skeletal muscle cells and skeletal muscle 
tissue. We then compared the transcriptomic and miRnome profiles of myoblasts, 
myotubes and skeletal muscle tissue. The findings are detailed in the following sections. 
2.3.1 Human myoblast, myotube and skeletal muscle tissue differential gene 
expression profile 
Upon differentiation of myoblasts into myotubes a total of 1010 genes were significantly 
(FDR=0.05) over expressed (≥1.5 log2 fold change) and 1593 genes were down regulated 
(≤ -1.0 log2 fold change). Skeletal muscle tissue showed considerable over expression of 
2481 genes (≥ 1.6 log2 fold change) and under expression of 2243 gens (≤ -1.5 log2 fold 
change)  with respect to myotubes (figure 2-1).    
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Figure 2-1: mRNA differential expression profile of myotube and skeletal muscle tissue. 
Number of genes found differentially up and down regulated is shown by the bar plots. The 
doughnut plot at the top of each bar plot shows the percentage of protein coding and non-protein 
coding genes. (NPC- Non protein coding, PC- Protein coding, Upreg in MT- Upregulated in 
myotubes, Dwnreg in MT- Down regulated in myotubes, Upreg in Sk Mus- Upregulated in 
skeletal muscle tissue, Dwnreg in Sk Mus- Down regulated in skeletal muscle tissue).     
      
We observed a correlation (R
2
 value) of 0.775 between the transcriptome of myoblasts 
and myotubes, whereas the transcriptome of skeletal muscle tissue showed a correlation 
(R
2
 value) of 0.562 with myotubes. Figure 2-2 (A&B) shows the plots of comparison 
between myoblasts, myotubes and skeletal muscle tissue. As is apparent from the plots, 
the degree of variance between the transcriptomes of skeletal muscle tissue and myotubes 
is higher than the variance between myoblasts and myotube transcriptomes. The smear 
plots in figure 2-3 (A&B) show that the differential expression of genes is much higher in 
skeletal muscle tissue.            
15% and 22.5% of protein coding genes showed more than 5X fold increase in myotubes 
and skeletal muscle tissue respectively. The genes have been listed in supplementary table 
S1-5 and S1-6. In myotubes MYBPC1, MYH8, DPYSL5, CASQ2, ATP1B4, CACNG1 
and MYH3 showed ≥ 8X fold increase. Whereas HBB, MB, PDK4, THBS4, SMTNL2, 
LBP, CD74, FABP4, C8orf22, CD93, LPL, RNASE1, RORC, CA3, PPP1R1A, DARC 
and IDI2 were the most prominent over expressed genes showing ≥ 9X fold increase in 
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skeletal muscle tissues when compared to myotubes. However, 9% and 19% genes 
showed > -4X fold and -6X fold decrease in myotubes and skeletal muscle tissue 
respectively.  
  
 
  
 
 
 
 
 
 
                                   A                                                                          B 
Figure 2-2: (A) Pairs-plot between the transcriptome of myoblast and myotube. These plots 
compare the transcriptome of myoblasts and myotubes. We performed the RNAseq in replica for 
both myoblasts and myotubes, the comparison of the transcriptome of the replicas are also shown 
here. (B) Pairs-plot between the transcriptome of myotube and skeletal muscle tissue. These 
plots compare the transcriptome of myotubes and skeletal muscle tissue. We performed the 
RNAseq in replica for both myotubes and skeletal muscle tissue, the comparison of the 
transcriptome of the replicas are also shown here.  
 
 
 
 
 
 
 
 
 
                                  
  
  A B 
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Figure 2-3: (A) Smear plot showing differential expression of genes between myoblasts and 
myotubes. (B) Smear plot showing differential expression of genes between myotubes and 
skeletal muscle tissue. Log fold-change of gene expression is shown by the vertical axis or Y-
axis.Genes below the zero level (on negative scale) show genes differentially down regulated and 
vice-versa. Red dots represent genes showing differential expression. Black dots represent genes 
which are not differentially expressed between the two samples. (Log FC- log2 Fold change, 
Average log CPM –log of count per million) 
 
2.3.1.1 Protein family genes upregulated in myotubes 
Members of many protein families were over expressed together, upon myotube 
formation. All those family specific genes have been listed in supplementary table S2-7. 
We observed some ABC transporter genes of ATP binding cassette family (ABC 
superfamily) were differentially over expressed. ABC transporter genes of ABCA1, 3, 6, 
8 and 9 from ABCA subfamily and ABCG1 showed >1.5x fold increase. mRNA for 
apolipoproteins D, E and apolipoprotein L1, 3, 4, 6 were also upregulated. ABS 2, 4, 14 
and 16 genes of ankyrin repeat and SOCS box-containing (ASB) family were over 
expressed. Some sub units of voltage dependent calcium channels (VDCC) were found 
upregulated. Alpha 1S subunit of L-type calcium channel (CACNA1S), alpha 1H subunit 
of T-type calcium channel (CACNA1H), beta subunit isoform 1, 4 (CACNB1, CACNB4) 
and gamma subunit genes CACNG 1, 4, 6 were >2x upregulated. Alpha and beta subunit 
genes of voltage gated sodium channels showed >2x increased expression. Genes for 
coiled coil domain containing proteins, CCDC141, 3, 39 and 69 also increased upon 
differentiation. Cyclin dependent kinase inhibitors CDKN1A, 1C and 3B expression was 
also found increased. Genes of collagen type I, III, IV, VIII, X, XI, XV, XVIII, XIX and 
XXI were found upregulated. Genes for members of insulin like growth factor binding 
protein family, IGFBP 2, 5, 7 were upregulated. A wide range of interleukins were also 
turned up. Subunits of Voltage gated potassium channel genes and some other genes of 
potassium channel subfamily were over expressed. Almost all the members of myosin 
class II, members of other myosin classes and many myosin light chain genes were 
strongly upregulated. Some protocadherin genes of protocadherin subfamily of cadherins, 
which have their role in homophilic adhesion and signalling, were also turned up. Many 
members of Solute carrier family (SLC group), which are membrane transport proteins 
had increase in their expression.  Many zinc finger protein genes showed slight 
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upregulation. Genes for FOX (Forkhead box) proteins which are a family of transcription 
factors were upregulated.   
2.3.1.2 Protein family genes upregulated in skeletal muscle tissue 
Similar to myotubes many members of ATB binding cassette (ABC superfamily) 
(ABCG1, ABCC 2, 6, 9, ABCB4, ABCA 5, 10) were > 2.5X fold increased in skeletal 
muscle tissue. Acyl CoA synthetase long, medium and short chain fatty acid family 
members (ACSL1, 5, ACSM5, ACSS1 and 2) were found to be >2 fold upregulated. 
Adenylate cyclase isoforms (ADCY 2, 4, 5 and 9) and Aldehyde dehydrogenase 1, 2, 5, 8 
family members (ALDH1A2, A3, L1 ALDH2, ALDH5A1 and ALDH8A1) were also >2 
fold over expressed. Members of ankyrin repeat and SOCS box-containing (ASB) family 
members (ASB2, 8, 10, 11, 12, 15, 16) were ≥ 3X fold increased. Isoforms of α-CA 
(carbonic anhydrase) family (CA1, 2, CA3 muscle specific, CA4, 8, 11) showed ≥ 3X 
fold increase, with CA3 showing 9X fold over expression. Chemokine (C-C motif) ligand 
8, 18, 21 were > 2.5X fold increased. 26 CD (cluster of differentiation) molecules showed 
> 2X fold up regulation. Cluster of differentiation is defined as a subset of cellular surface 
receptors (epitopes) that identify cell type and stage of differentiation, which are 
recognised by antibodies. C-type lectin domain superfamily members (CLEC10A, 12A, 
14A, 1A, 5A, 7A, 2B, 4E and 4G) which play diverse functions such as cell adhesion, cell 
– cell signalling, glycoprotein turnover, roles in inflammation and immune response also 
were upregulated. Cytochrome C oxidase (COX) is the terminal enzyme of the 
mitochondrial respiratory chain. COX subunits (COX4I2, COX5A, COX6A2, COX6C, 
COX7A1, COX7B and COX7C) were ≥ 2X fold upregulated. CXC chemokine receptors 
are integral membrane proteins that specifically bind and respond to cytokines of CXC 
chemokine family. CXC chemokine is one of the subfamily of chemokines. Chemokines 
are a family of cytokines or signalling proteins secreted by cells.  CXC ligands (CXCL1, 
2, 3, 14) and CXC receptors (CXCR1, 2, 4) were ≥ 2X fold upregulated. DEAD box 
proteins are involved in assortment of metabolic processes that typically involve RNAs. 
DEAD box polypeptides (DDX11, 12, 51 and 59) also showed ≥ 2X fold increase. Dual 
specificity phosphatase is a form of phosphatase that can act upon tyrosine or 
serine/threonine residues. Many DUSP enzymes (DUSP1, 13, 16, 2326, 27, 3 and 8) were 
≥ 2X fold upregulated. Many Eukaryotic translation initiation factors (eIF) which are 
involved in the initiation phase of eukaryotic translation were upregulated in skeletal 
muscle tissue. Hemoglobin subunit members (HBA1, 2, HBB, HBD, HBG1, 2) were 
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found to be ≥ 2.5X fold increased. Some genes of Troponin complex protein which is 
integral to muscle contraction were also ≥ 2X fold increased. Genes of some interleukins 
(ILs), and interleukin receptors were upregulated.   
The major histocompatibility complex (MHC) is a set of cell surface molecules that 
mediate interactions of leukocytes, also called white blood cells (WBCs), which 
are immune cells, with other leukocytes or body cells. MHC determines compatibility of 
donors for organ transplant as well as one's susceptibility to an autoimmune disease via 
crossreacting immunization. Many MHC genes were also found upregulated.  Members 
genes of Leukocyte Ig-like receptors (LIRs) which are a family of immunoreceptors 
expressed predominantly on monocytes and B cells and at lower levels on dendritic cells 
and natural killer (NK) cells also showed increase in expression. NADH dehydrogenase 
(ubiquinone) is an enzyme of the respiratory chains. It catalyzes the transfer 
of electrons from NADH to coenzyme Q10 (CoQ10) and, in eukaryotes, it is located in 
the innermitochondrial membrane. It is one of the entry enzymes of oxidative 
phosphorylation in the mitochondria. Many NADH enzyme subunit genes were increased 
in expression. Many Phosphoprotein phosphatase 1 (PP1) genes which belongs to a 
certain class of phosphatases known as protein serine/ threonine phosphatases also turned 
up their expression.  PP1 has been found to be important in the control 
of glycogen metabolism, muscle contraction, cell progression, neuronal activities, 
splicing of RNA, mitosis, cell division, apoptosis, protein synthesis, and regulation of 
membrane receptors and channels. A huge number of genes belonging to solute carrier 
family (SLC) were over expressed. SLC group members transport diverse type of solutes 
which include charged and uncharged organic molecules as well as inorganic ions. Many 
zinc finger proteins were also upturned significantly. (Details to be found in 
supplementary table S2-8).                   
2.3.1.3 Functional annotation and pathway analysis of differentially expressed genes 
Using the online tool DAVID and KEGG pathways we found the GO terms and pathways 
over represented in myotubes relative to the myoblast and in skeletal muscle compared to 
myotubes.  
Genes over expressed in myotubes were those involved in biological processes related to 
skeletal muscle development (muscle system process, muscle organ development, muscle 
contraction and other striated muscle specific activities). Whereas genes significantly 
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down regulated were mainly associated with cell cycle regulation (nuclear division, 
mitosis). For the upregulated genes in skeletal muscle tissue we identified, immune 
response, defence response, inflammatory response were significantly over represented 
GO biological process terms. Subsets of functional groups are shown in supplementary 
tables (S2-1 to S2-4).  
Differentially over expressed genes were, analysed using KEGG pathway. Pathways are 
shown in table 2-1 and 2-2. Highest number of genes belonged to metabolic pathways, 
which is described as a set of complex metabolic networks (1).    
 
KEGG pathways Number 
of genes 
Gene names 
Metabolic pathways  48 ACSL1, ADC, ADH1B, AGL, AKR1C3, ALOX15B, AMPD1, AOC3, AOX1, 
B3GALT2, CKB, CKM, CKMT2, COX6A2, CYP19A1, CYP2J2, DHCR7, 
ENO3, GALNT16, GATM, GGT5, HMGCS1, HSD11B1, IDI1, INPP4B, 
INPP5K, ISYNA1, MAN1C1, MSMO1, ND3, ND5, NDUFA4L2, NNMT, 
PGAM2, PHOSPHO1, PIK3C2B, PIPOX, PLA2G16, PLA2G4C, PLCE1, 
PTGDS, PTGS1, PYGM, SQLE, ST6GAL1, TM7SF2, TYMP, WBSCR17 
Hypertrophic cardiomyopathy 
(HCM) 
30 ACTC1, CACNA1S, CACNB1, CACNB4, CACNG1, CACNG4, CACNG6, 
DAG1, DMD, IGF1, ITGA1, ITGA4, ITGA6, ITGA7, ITGB8, LAMA2, MYH6, 
MYH7, MYL2, MYL3, PRKAA2, PRKAB2, PRKAG3, RYR2, SGCD, SGCG, 
TGFB3, TNNC1, TNNT2, TTN 
Pathways in cancer  30 ARNT2, BCR, CDKN1A, CDKN2B, COL4A1, COL4A4, DAPK1, DAPK2, 
EGLN3, EPAS1, FGF13, FGF9, FOXO1, FZD4, FZD9, IGF1, ITGA6, JUP, 
LAMA2, LAMA5, PAX8, PDGFA, PDGFB, RUNX1T1, RXRG, STAT5A, 
TGFB3, WNT10A, WNT11, ZBTB16  
Dilated cardiomyopathy  29 ACTC1, ADCY1, ADCY2, CACNA1S, CACNB1, CACNB4, CACNG1, 
CACNG4, CACNG6, DAG1, DMD, IGF1, ITGA1, ITGA4, ITGA6, ITGA7, 
ITGB8, LAMA2, MYH6, MYH7, MYL2, MYL3, RYR2, SGCD, SGCG, 
TGFB3, TNNC1, TNNT2, TTN 
Focal Adhesion 26 ACTN2, CAV3,CCND2, COL11A1, COL1A1,  COL3A1,  COL4A1,  COL4A4,  
COMP, IGF1,  ITGA1,  ITGA4,  ITGA6,  ITGA7,  ITGB8,  LAMA2,  LAMA5, 
MYL2,  MYLK4,  MYLPF,  PDGFA,  PDGFB, PDGFD, PPP1R12B,  
RAPGEF1,  SHC2 
PI3K-Akt signaling pathway  25 BCL2L11; CCND2; CDKN1A; COL11A1; COL1A1; COL3A1; COL4A1; 
COL4A4; COMP; DDIT4; FGF13; FGF9; IGF1; ITGA1; ITGA4; ITGA6; 
ITGA7, ITGB8LAMA2, LAMA5, PDGFA, PDGFB, PDGFD, PPP2R3B, 
PRKAA2 
Regulation of actin 
cytoskeleton  
21 ACTN2; ARHGEF6; CHRM4; CYFIP2; FGF13; FGF9; ITGA1,ITGA4; ITGA6; 
ITGA7; ITGB8; LIMK2; MRAS; MYH14; MYL2; MYLK4,MYLPF; PDGFA; 
PDGFD; PPP1R12B 
Arrhythmogenic right 
ventricular cardiomyopathy 
20 ACTN2; CACNA1S; CACNB1; CACNB4; CACNG1,CACNG4; CACNG6; 
DAG1,DMD; ITGA1; ITGA4; ITGA6,ITGA7; ITGB8; JUP; LAMA2; PKP2; 
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(ARVC) RYR2; SGCD; SGCG 
HTLV-I infection  20 ADCY1; ADCY2; CCND2; CDKN1A; CDKN2B; EGR2; FZD4; FZD9; ICAM1; 
IL15RA; IL1R1; MRAS; PDGFA; PDGFB; STAT5A; TGFB3;  
TP53INP1;VCAM1; WNT10A; WNT11 
MAPK signalling pathway 19 CACNA1H; CACNA1S; CACNB1; CACNB4; CACNG1; CACNG4; CACNG6;  
DUSP4; FGF13; FGF9; GADD45G; IL1B; IL1R1; MEF2C; MRAS;  
PDGFA; PDGFB; PLA2G4C; TGFB3 
 
Table 2-1: KEGG pathways enriched for genes differentially up-regulated in Myotubes. The 
table shows the name of the enriched pathways, the number of genes involved in corresponding 
pathways and the gene names.   
 
KEGG pathways Number 
of Genes 
Gene Name 
Metabolic pathways  153 ACACB; ACADM; ACADS; ACAT1; ACO2; ACSL1; ACSL5; 
ACSM5;ACSS1; ACSS2; ADH1A; ADH1B; ADH4; ADH5, 
ADSSL1;AGPAT9;AKR1B10;AKR1C3;ALAS2;ALDH1A2;ALDH1A3; 
ALDH2;ALDH5A1; ALDOA;ALOX5;AMPD1; AMPD3;AMY1A; 
AMY2A; AMY2B; AOC3;ARG1; ARG2;ATP5E;  
B3GALT4; B3GNT5; B4GALNT1;BDH1;CD38;CDO1; CES1;  
CHDH; CKM; CKMT2; CMBL; CMPK2; COX17; COX4I2;  
COX5A; COX5B;COX6A2;COX6C;COX7B;COX7C;CYP1A1;  
CYP27A1;DCXR;DGAT1;DGAT2;DGKG;DHRS3;DHRS4;EPHX2;  
FBP2;FUT1;GALNT6;GAMT;GAPDH;GCNT2;GLUL;GOT2;GPT;  
HADH;HADHA;HADHB;HK3;HMGCS2;HSD17B8;HSD3B1;HYAL1;  
IDH2;IDH3A;IDI2;IDO1;IMPA2,KL;KYNU;MAN2A2;MAOA;  
MAOB;MGAT3; MGAT4A; MLYCD; MOCS1; NDUFA12,NDUFA2; 
NDUFA3; NDUFA4; NDUFA4L2; NDUFA5; NDUFA6;NDUFB1;  
NDUFB10;NDUFB3;NDUFB4;NDUFB8;NDUFB9;NDUFS3;NMNAT3;  
NNMT; NOS1; NT5C1A; NT5M; PCK1; PFKM; PGAM2; PGM1;  
PIP5K1B;PLA2G2A; PLA2G4C; PLA2G4F; PLA2G5; PLB1;  
PLCB2; PLCD4; PLCG2; PNMT;POLR2I; POLR2J; POLR2J2;  
POLR3GL; PRODH;PYCR1; PYGM; SDHB; SDHD; SHMT1;  
ST3GAL3; ST6GALNAC1; ST6GALNAC3;TBXAS1; TPO; UGP2;  
UPP1; UQCRB; UQCRC1; UQCRFS1 
Epstein-Barr virus infection 50 BCL2; CD38; CDKN1B; FGR; HDAC5; HLA-B; HLA-C; HLA-DPA1; 
HLA-DPB1;HLA-DQA2; HLA-DQB1;HLA-DRA; HLA-DRB4; 
HLA-E; HLA-F; HLA-G; HSPA1A;HSPA2; HSPA6;IL10RA;  
MAP2K6; MAP3K14; MAPK12; NEDD4; NFKBIA; PIK3CB;  
PIK3R5; PLCG2; POLR2I; POLR2J; POLR2J2;POLR3E;  
POLR3GL;PSMC1; PSMC4; PSMC5; PSMC6; PSMD12;PSMD13;  
PSMD14; PSMD3; PSMD4; PSMD7; PSMD8; SHFM1; SPI1;  
SYK; TNFAIP3; YWHAE 
Cytokine-cytokine receptor 
interaction  
47 AMHR2; CCL18; CCL21; CCL8; CCR1; CD40; CNTFR; CSF1R; 
CSF2RA; CSF2RB; CSF3; CSF3R; CX3CL1; CXCL1; CXCL14; 
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CXCL2; CXCL3; CXCR4; EGF; EPOR; FIGF; FLT1; FLT4; GHR; 
IL10RA; IL12RB2; IL15RA; IL17RB; IL18; IL18RAP; 
 IL1R2; IL2RG; IL3RA; IL6R; IL8; INHBB; KDR; OSM;  
PDGFB; RELT; TNF; TNFRSF14; TNFRSF1B; TNFRSF4; TNFSF10; 
TPO 
Alzheimer's disease  43 ATP2A1; ATP2A2; ATP5D; ATP5E; ATP5H; ATP5J; COX4I2;  
COX5A; COX5B; COX6A2; COX6C; COX7A1;COX7B;COX7C; 
CYCS; GAPDH; LPL;MAPT; NDUFA12; NDUFA2; NDUFA3;  
NDUFA4;NDUFA4L2; NDUFA5; NDUFA6; NDUFB1; NDUFB10;  
NDUFB3; NDUFB4; NDUFB8; NDUFB9;NDUFS3;NOS1; PLCB2; 
PPP3CC; RYR3; SDHD; SNCA; TNF; UQCRB; UQCRC1; UQCRFS1 
MAPK signaling pathway  43 ARRB2; ATF4; CACNA2D3; CACNB2; CD14; DUSP1; DUSP16;  
DUSP3; DUSP8; ECSIT; EGF; FGF10; FOS; GADD45A;  
GADD45B; GADD45G; HSPA1A;  HSPA2; HSPA6; IL1R2; MAP2K6; 
MAP3K14; MAPK12; MAPKAPK3; MAPT; MKNK2; 
 NFATC1; NR4A1; NTRK1; NTRK2; PDGFB; PLA2G4C;  
PLA2G4F; PPM1B; PPP3CC; PRKCB; PTPN5; RASGRF2; 
 RASGRP2; RASGRP3; RPS6KA1; TNF; ZAK 
Huntington's disease  43 ATP5D; ATP5E; ATP5H; ATP5J; COX4I2; COX5A; COX5B;  
COX6A2; COX6C; COX7A1; COX7B; COX7C; CYCS; NDUFA12; 
NDUFA2; NDUFA3, NDUFA4; NDUFA4L2; NDUFA5; NDUFA6;  
NDUFB1; NDUFB10; NDUFB3; NDUFB4; NDUFB8; NDUFB9;  
NDUFS3; PLCB2; POLR2I; POLR2J; POLR2J2; PPARGC1A;  
PPIF; SDHB; SDHD; SLC25A4; SOD1;SOD2; TAF4B; UQCRB;  
UQCRC1; UQCRFS1; VDAC1 
PI3K-Akt signaling pathway  42 ANGPT2; ATF4; BCL2; CDKN1B; CHAD; COL4A3; CSF1R; CSF3; 
CSF3R; EFNA1; EGF; EIF4B; EIF4EBP1; EPOR; FGF10; FIGF; FLT1; 
FLT4; GHR; GNG5; IGF1;IL2RG; IL3RA; IL6R; INSR; ITGA9; ITGB4; 
KDR; NR4A1; OSM; PCK1; PDGFB; PIK3CB; PIK3R5; PPP2R5A; 
PRKAA2; RHEB; SYK; THBS4; TLR2;YWHAE 
 
Table 2-2: KEGG pathways enriched for genes differentially up-regulated in Skeletal muscle 
tissue. The table shows the name of the enriched pathways, the number of genes involved in 
corresponding pathways and the gene names.     
 
2.3.2 miRNA expression profiling of myoblasts, myotubes and skeletal muscle tissue 
miRNA are well conserved and evolutionarily ancient component of genetic regulation in 
eukaryotic organisms
 5,6
. So, it was of significant interest for us to carry out an in-depth 
study of miRNA expression profiles at each developmental stage of skeletal muscle (i.e. 
from mono nucleated myoblasts to multinucleated myotubes to skeletal muscle tissue). 
Differential expression of miRNA was found using edgeR software with an FDR (false 
discovery rate) of 0.05. We performed the miRNA-seq in replica for each sample to have 
more robust and reliable set of results.   
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2.3.2.1 miRNA profile of myotubes 
Using NGS we found that more than 400 miRNA were expressed at a substantial level in 
myoblasts and myotubes. With edgeR software we found the differential expression of 
miRNA between myoblasts and myotubes. The correlation coefficient (R
2
 value) of 
miRNA expression between myoblasts and myotubes was found to be 0.895, which 
indicates high correlation between the two samples. We found 24 miRNA were over 
expressed and 16 miRNA were under expressed in myotubes. Table 2-3 shows the list of 
differentially expressed miRNA in myotubes.  
hsa-miR-1, 133 and 206 (2,3,4) have their role very well documented in muscle growth 
and differentiation. We found that along with miR-1, miR-133a and miR-206, miR-139-
5p and miR-4488 were > 5 log2 fold upregulated upon differentiation into myotubes. 
 
Over Expressed   Under Expressed   
miRNA Log2 FC P value miRNA Log2 FC P value 
hsa-miR-1 7.91 2.94E-18 hsa-miR-222-5p -3.59 1.74E-06 
hsa-miR-133a 7.06 1.68E-15 hsa-miR-155-3p -3.56 1.33E-05 
hsa-miR-139-5p 6.12 2.830E-11 hsa-miR-155-5p -3.51 2.18E-06 
hsa-miR-4488 5.75 1.23E-11 hsa-miR-15b-5p -3.21 1.38E-05 
hsa-miR-206 5.55 6.03E-12 hsa-miR-221-3p -3.09 1.74E-05 
hsa-miR-133b 4.60 2.89E-09 hsa-miR-7p -2.67 0.00021 
hsa-miR-95 3.94 0.00012 hsa-miR-15a-3p -2.57 0.0004 
hsa-miR-486-5p 3.67 7.14E-05 hsa-miR-3065-5p -2.55 0.00208 
hsa-miR-26b-5p 2.92 8.57E-05 hsa-miR-221-5p -2.48 0.00051 
hsa-miR-668 2.89 0.00163 hsa-miR-154-3p -2.37 0.00086 
hsa-miR-181a-5p 2.62 0.00021 hsa-miR-18a-3p -2.26 0.00199 
hsa-miR-1264 2.52 0.00127 hsa-miR-1285-3p -2.16 0.00296 
hsa-miR-378d 2.44 0.0036 hsa-miR-409-3p -2.14 0.00207 
hsa-miR-501-5p 2.37 0.00092 hsa-miR-16-2-3p -2.09 0.00276 
hsa-miR-660-5p 2.36 0.00075 hsa-miR-376b-3p -2.06 0.00339 
hsa-miR-188-5p 2.34 0.00096 hsa-miR-29b-3p -2.01 0.00356 
hsa-miR-128 2.33 0.00086    
hsa-miR-362-5p 2.23 0.00152    
hsa-miR-532-3p 2.22 0.00146    
hsa-miR-26a-5p 2.05 0.00297    
hsa-miR-664a-3p 2.05 0.00334    
hsa-miR-188-3p 2.02 0.00439    
hsa-miR-532-5p 1.94 0.00488    
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Table 2-3: List of miRNA differentially over and under expressed in myotubes. All miRNA up 
and down regulated in myotubes as compared to myoblasts are listed in the table.     Each miRNA 
is shown with their log2 fold change value and P-value. P value gives the reliability of the 
analysis. Lesser the P-value, more reliable is the results. 
 
 
 
 
 
 
 
 
 
 
 
                                A                                                                              B  
Figure 2-4: (A) Pair-plot of miRnome between myoblasts and myotubes. Pairs plot compares 
the miRnomes of myoblasts and myotubes. The plots show the extent of similarity and differences 
between the samples compared. The pairs plot between replica of samples are also shown (MB_1 
– Myoblast replica 1, MB_2 – Myoblast replica 2, MT_1 – Myotube replica 1, MT_2 – Myotube 
replica 2). (B) Smear-plot between miRnome of myoblast and myotube. Smear plot shows the 
differential expression of miRNA between myoblast and myotube. Dots above zero show 
differentially upregulated miRNA and vice versa. (logFC- log2 Fold change, Average log CPM-
……..) 
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Figure 2-5: miRNA expression profile of myotubes. Shown are the differentially expressed 
miRNA in myotubes as compared to myoblasts. 
 
2.3.2.2 miRNA expression profile in skeletal muscle tissue 
The miRnome expression profile of skeletal muscle tissue was quite different and distinct 
from that of myotubes. The correlation coefficient (R
2
 value) was 0.432, which indicates 
a very poor correlation between the miRNA expression profiles of myotubes and skeletal 
muscle tissue. Differential expression profile of miRNA in skeletal muscle tissue is 
shown in figure 2-7 and by Pairs and scatter plots also (figure 2-6 A & B). 
90 miRNA were significantly over expressed and 191 miRNA were considerably down 
regulated in skeletal muscle tissue as compared to myotubes. The list of all these miRNA 
is shown in supplementary tables S2-5 and S2-6.  
Bar plot of figure 2-8 shows all those miRNA which showed > 5 log2 FC in skeletal 
muscle tissue as compared to myotubes.  
 
 
 
   
 
 
 
   
 
                                  
                                 A                                                                                 B 
Figure 2-6: (A) Pairs-plot between miRnome of myotubes and skeletal muscle tissue. Pairs plot 
compares the miRnomes of myoblasts and myotubes. The plots show the extent of similarity and 
differences between the samples compared. The pairs plot between replica of samples are also 
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shown (MT_1 – Myotube replica 1, MT_2 – Myotube replica 2, SK_1 – Skeletal muscle replica 1, 
SK_2 – Skeletal muscle replica 2). (B) Smear-plot between miRnome of myotube and skeletal 
muscle tissue. Smear plot shows the differential expression of miRNA between myotube and 
skeletal muscle tissue. Dots above zero show differentially upregulated miRNA and vice versa. 
(logFC- log2 Fold change, Average log CPM-average of count per million.) 
 
 
 
Figure2-7: miRNA expression profile in skeletal muscle tissue. Shown are all the differentially 
expressed miRNA in skeletal muscle tissue as compared to myotubes. 
 
Both -3p and -5p arms of miR-101, miR-126, miR-142, miR-144, miR-30b, miR-338, 
miR-340, miR-378a, miR-486 and miR-499a were differentially upregulated in skeletal 
muscle tissue. Many IsomiRs were differentially over and under expressed in skeletal 
muscle tissue. Table 2-4 shows the list of those isomiRs.    
 
IsomiRs Upregulated IsomiRs Downregulated 
hsa-miR-133a, b hsa-miR-125a, b 
hsa-miR-146a, b hsa-miR-130a, b 
hsa-miR-208a, b hsa-miR-181a, b, c 
hsa-miR-30a, b, c, d, e hsa-miR-193a, b 
hsa-miR-378a, c, d, f, i hsa-miR-199a, b 
hsa-miR-517a, b hsa-miR-27a, b 
 hsa-miR-301a, b 
 hsa-miR-323a, b 
 hsa-miR-34a, b, c 
 hsa-miR-376a, b, c 
 hsa-miR-487a, b 
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 hsa-miR-92a, b 
 hsa-miR-99a, b 
 
Table 2-4: IsomiRs differentially up and down regulated in skeletal muscle tissue. Enlisted are 
the isomiRs found over and under expressed in skeletal muscle tissue.    
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2.3 Common miRNA expression patterns   
 
There are miRNA found commonly expressed differentially in both myotubes and 
skeletal muscle tissue. Some of these miRNA were upregulated in myotubes whereas 
down regulated in skeletal muscle tissue and vice versa. Those miRNA have been listed 
in table 2-5.    
miRNA Up reg in 
Myotube 
(log2FC) 
Up reg in 
Skeletal 
muscle 
(log2FC) 
Down reg in 
Myotube 
(log2FC) 
Down reg in 
Skeletal 
muscle 
(log2FC) 
hsa-miR-1 7.912101 5.948486 -- -- 
hsa-miR-133a 7.058043 5.222945 -- -- 
hsa-miR-139-5p 6.117224 2.454135 -- -- 
 
0 5 10 15
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Figure 2-8: miRNA showing more than 5 
log 2 fold increase in skeletal muscle tissue. 
miRNA showing more than 5 log2 FC in 
skeletal muscle tissue as compared to 
myotubes are represented in this bar graph. 
Y-axis shows the miRNA and X-axis shows 
log2 fold change. 
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hsa-miR-4488 5.748539 -- -- -9.42245 
hsa-miR-133b 4.597984 2.927984 -- -- 
hsa-miR-95 3.941105 7.256696 -- -- 
hsa-miR-486-5p 3.669232 4.304105 -- -- 
hsa-miR-26b-5p 2.918038 3.321551 -- -- 
hsa-miR-181a-5p 2.615645 -- -- -4.66044 
hsa-miR-378d 2.435125 3.44239 -- -- 
hsa-miR-501-5p 2.374571 -- -- -3.97934 
hsa-miR-660-5p 2.356814 -- -- -2.11302 
hsa-miR-188-5p 2.344865 -- -- -4.80874 
hsa-miR-362-5p 2.230706 -- -- -3.51081 
hsa-miR-532-3p 2.225932 -- -- -5.49949 
hsa-miR-188-3p 2.022257 -- -- -5.83725 
hsa-miR-532-5p 1.937058 -- -- -8.57967 
hsa-miR-222-5p -- -- -3.58772 -4.49821 
hsa-miR-221-3p -- -- -3.08959 -4.10406 
hsa-miR-15a-3p -- -- -2.56554 -4.67183 
hsa-miR-221-5p -- -- -2.47864 -4.65151 
hsa-miR-154-3p -- -- -2.36679 -2.23824 
hsa-miR-409-3p -- -- -2.13655 -4.50168 
hsa-miR-376b-
3p 
-- -- -2.05503 -2.57024 
Table2-5: miRNAs found common between myotube and skeletal muscle tissue. Listed are the 
miRNA differentially expressed both in myotube and skeletal muscle tissue. miRNA highlighted in 
blue are over expressed in myotube but under expressed in skeletal muscle tissue.  
2.3.3 Ago2 associated mRNA 
We wanted to investigate the mRNA repertoire which is associated with argonaute 2 
(Ago2) protein, which is a member of RISC complex in order to have a better idea of 
mRNA pool which is likely under the regulation of miRNA. We performed Ago2-RNA 
immunoprecipitation for both myoblast and myotube cells, in replica. The RIP sample 
was enriched for poly(A) RNA using oligo dT column and sequenced using SOLiD 
sequencing. We then compared these results with the non Ago2 pull down RNA 
population from myoblasts and myotubes.  The mRNAs which were enriched with Ago2 
pull down as compared to non-pull down most likely are the sequences which are directly 
under the control of miRNA regulation.  
We found 1493 and 1979 genes were enriched with Ago2 pulldown in myoblasts and 
myotubes respectively. The comparison between pull down and non pull down samples 
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are shown by pairs plot of figure 2-9. Immunoblotting result of Ago2-RIP is shown in 
figure 2-10. 
 
 
 
 
 
 
 
 
 A                                                                         B 
Figure 2-9: Pairs plot between Ago2 pull down and non-pull down RNA seq results for (A) 
Myoblasts (B) Myotubes (Mb_replica+ mRNA_myoblast = name of non pull down myoblast RNA 
seq, AGO2_MB_mRNA + AGO2MB1 = name of Ago2 pull dowm RNA seq for myoblasts, 
Mt_replica+mRNA_myotube = name of non pull down myotube RNA seq, 
AGO2_MT_mRNA+AGO2MT1 =  name of Ago2 pull dowm RNA seq for myotubes). 
 
 
 
 
 
 
 
 
 
2.3.3.1 Ago2 enriched mRNA in myoblasts 
To understand the list of genes better, we found out those genes which were enriched with 
the Ago2 pull down in myoblast and genes which were under expressed in myoblasts. 
Our rationale behind this is, genes down regulated by miRNA should be associated with 
  
 
Figure 2-10: ECL image of Ago2 pull down 
in CHQ5B myoblast and myotube cells. We 
observed that the Ago2 concentration 
seemed higher in myotubes than in 
myoblasts. 
85 kD 
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Ago2 protein and hence should be enriched when pulled down with argonaute, when their 
actual expression in the cell remains low if is down regulated by miRNA. We found 173 
such genes in myoblasts. List can be found from supplementary table S2-11. We also 
carried out biological process enrichment using online software DAVID for these genes 
and found that they were skeletal muscle process associated biological terms like muscle 
system process, muscle contration, muscle tissue development etc (supplementary table 
S2-13).  
2.3.3.2 Ago2 enriched mRNA in myotubes 
Following the rationale mentioned in the above section, we did the similar analysis for 
myotubes and found 134 genes down regulated in myotubes but enriched with Ago2 pull 
down in myotubes (supplementary table S2-12). GO analysis of biological process terms 
showed enrichment of DNA metabolic process, protein polymerization and carbohydrate 
catabolic process terms (supplementary table S2-14).  
Although there are a huge number of genes found enriched with Ago2 pull down, but we 
do not have a convincing explanation for them, so we have only highlighted those genes 
which our experimental evidence suggest to be the direct candidates under miRNA 
regulation. 
2.4 Discussion: 
Aiming at understanding the molecular basis of skeletal muscle development, we report 
the high-throughput sequencing analysis of mRNA and small RNA transcriptome of 
primary human muscles. Transcriptome analysis is useful in understanding the relation 
between genome and functioning of the cells (13). In this study we have addressed the 
mRNA and miRNA constitution of primary human muscle cells at both the myoblast and 
myotube stage of development. We did the profiling of mRNA and miRNA for adult 
skeletal muscle as well. The expression level of both mRNA and miRNA displayed a 
broad range. Our study provides the large scale characterization of the transcriptome and 
its modulation during the stages of muscle cell proliferation and differentiation and of 
skeletal muscle tissue.  
We found far more number of genes differentially expressed between myotubes and 
skeletal muscle tissue. The overlap between of transcriptomes of myotubes and skeletal 
muscle tissue was less (R
2
 value = 0.56) as compared to the extent of overlap between 
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myoblasts and myotubes (R
2
 value = 0.77). This was expected as the transition from a 
cellular stage to next is not as complicated as from becoming tissue from cell. On 
differentiation we found many genes for specific protein families were upregulated. ABC 
superfamily members, which are transmembrane proteins and utilise the energy of ATP to 
carry out biological process of substrate translocation, RNA translation and DNA repair 
(14, 15) were upregulated in myotubes as well as skeletal muscles. Genes from ASB 
family were also upregulated. Ankyrin and SOCS box containing proteins have their role 
in fixing contractile apparatus to muscle membrane (16). VDCC subunit genes have their 
role in skeletal muscle differentiation were also upregulated (17). Genes for Voltage 
gated sodium and potassium channels were also turned up at this level of muscle 
development. Some Fork head (FOX) protein genes showed upregulation. Role of FoxO 
in preventing muscle wasting is well documented (18, 19). In skeletal tissue we found 
members of troponin complex protein genes upregulated. Along with many protein 
families whose role in muscle is known we found many chemokine family, interleukin, 
interleukin receptors and major histocompatibility complex family member genes were 
significantly upregulated in skeletal muscle tissue, but they were not turned up in 
myotubes.  
With the pathway analysis we found, metabolic pathways were the most pronounced 
pathways with highest number of altered genes, after differentiation and at the tissue 
level. This shows that cells undergo major metabolic changes at each stage of 
development from proliferative stage to becoming tissue. Many altered genes in myotubes 
and skeletal muscle belonged to PI3k-Akt and MAPK signalling pathways, which are 
very well documented pathways in muscle (20, 21, 22). We performed GO analysis 
separately for genes differentially up and down regulated. The Grouping into GO 
functional classes provided insights into the function of differentially expressed genes. 
GO analysis revealed several interesting classes. Genes involved in muscle system 
process, striated muscle contraction, muscle organ development, contractile fiber, I band, 
sarcomere, biological and cellular compartment terms were remarkable upregulated on 
myotube formation. Significant cell cycle function terms like cell cycle processes like M-
phase, nuclear division, mitosis, cell cycle process, chromosome, condensed chromosome 
contained genes down regulated upon myotube formation. So, the GO analysis reflected 
the transition of entire transcriptome from proliferative phase of myoblast to muscle 
specific non dividing state of myotubes. The interesting thing we found with gene 
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ontology for skeletal muscle tissue was the marked enrichment of biological process 
related to immune response, defence response, response to wounding, inflammatory 
response along with other biological process of muscle contraction, cellular respiration, 
electron transport chain. Muscle cells after differentiation although did not show any 
immunogenic capacity. GO terms of extracelluar matrix organization, extracellular parts 
were enriched for genes down regulated in skeletal muscle tissue. May be the 
immunogenic capacity is only acquired after becoming tissue and not in the cells by 
themselves.  
miRNA analysis showed more miRNA were down regulated in skeletal muscle tissue in 
comparison with myotubes than were in myotubes compared to myoblasts.  We also 
looked for miRNA common between myotubes and skeletal muscle tissue. We found 
many miRNA which are differentially upregulated after myotube formation but are not 
studied adequately yet. So we focused on their functional analysis, which is discussed in 
the following chapter. 
Since RNA seq gives a huge amount of data and a lot of aspects look very interesting as 
well worth investigating further. But distilling down that vast amount of information into 
one single interesting thing is extremely difficult. Here we had the entire knowledge of 
muscle transcriptome from cells to tissue and we also had the knowledge of miRNA 
expression which are important modulators of post transcriptional regulation. In order to 
understand this huge amount of information in a biologically meaningful way, we wanted 
to find out how the two set of RNAs (i.e mRNA and miRNA) interact with each other. 
The straight forward way to do so was by performing Ago2 RIP and then carry out RNA 
seq analysis. This provides a simple and direct experimental method to identify mRNA 
targets. We performed Ago2-RIP in myoblasts and myotubes. We then extracted the 
poly(A) from the immunoprecipitated complexes and performed RNA seq analysis. To 
find out the genes enriched with Ago2 we compared sequences with the total gene pool of 
non Ago2 pull down. We found several genes enriched with Ago2. We then compared the 
enriched genes, with the genes turned down in myoblasts and myotubes. We found 171 
such genes in myoblasts and 132 genes in myotubes. We found many muscle structural 
genes were enriched with Ago2 in myoblasts including MYOG which is a differentiation 
marker. Since myoblast is still a proliferative state where in muscle specific genes are not 
turned up (as we have shown with our RNA seq results), Ago2 enrichment of muscle 
structural genes indicate them to be under miRNA regulatory control. With GO analysis 
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of these genes we found them enriched for biological processes of muscle contraction, 
muscle development, regulatory processes. Genes enriched with Ago2 in myotubes 
consisted of transcription factors like PAX7, MYF5, MYF6, HOXA11and HOXA9. Pax7 
is known to be down regulated for muscle differentiation (23). HoxA11 is known to be 
under miR-181 regulation in muscle (9). GO of genes enriched with Ago2 showed 
significant enrichment for DNA metabolic processes. Since the cells upon differentiation 
cease to multiply, genes related to DNA replication, ligation or strand elongation are 
probably turned down. Our experimental evidences and literature curation shows the 
genes enriched with Ago2 pull down in myoblasts and myotubes are very likely to be 
under miRNA control. Although, it will certainly need further more experimental 
evidence to verify and validate which miRNA act on which mRNA. A transcriptome wide 
gene comparison between cellular development stages and adult tissue has not been 
described before to our knowledge.  
In summary, we have demonstrated the total pool of differentially expressed genes in 
human myoblasts, myotubes and adult skeletal muscle. We have also found differential 
expression of miRNA and with Argonaute-2 pull down we have been able to find those 
genes which are most likely under the control of miRNA regulation.    
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Chapter-3 
 
Functional analysis of hsa-miR-139-
5p, hsamiR-532-5p, hsa-miR-660-5p 
and hsa-miR-92a-3p in human 
skeletal myoblasts 
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3.1 Introduction: 
Based on the miRnome studies performed on skeletal muscle cells, we found out many 
differentially expressed miRNA between myoblasts and myotubes. In this chapter I focus 
on the functional analysis of hsa-miR-206, hsa-miR-139-5p, hsa-miR-532-5p, hsa-miR-
660-5p and hsa-miR-92a-3p. The reason behing selection hsa-miR-139-5p, hsa-miR-532-
5p and hsa-miR-660-5p is their differential upregulation in myotubes and they are less 
studied miRNAs with regards to muscle biology. hsa-miR-206 however is widely 
reported as an important and specific miRNA during muscle cell differentiation and 
proliferation (1,2,3), so I chose to use hsa-miR-206 as a positive control for the 
experiment. hsa-miR-92a-3p is upregulated in myotubes however not differentially, but 
this miRNA is one of the highly expressed miRNAs thereby making itself a molecule of 
interest for deeper functional analysis. The functional significance of miRNAs was 
studied by creating transient transfectants with miRNA mimics. To investigate the 
influence of miRNAs, we transfected miRNAs into human skeletal muscle cells (CHQ5B 
cells) and performed the genome wide expression analysis using NGS. We decided to 
perform the whole transcriptome analysis at two time points of 12 hours and 24 hours 
after miRNA mimic transfection. At 12 h time point we wanted to see the immediate 
impact and after 24 hours the prolonged effect of miRNA over expression. We had a 
negative control with which we compared each miRNA to find out the differential 
expression of genes caused by miRNA over expression. Our intention was not to find out 
the likely targets for these miRNAs, but to observe the overall impact these miRNA cast 
on the myoblast cells and if their over expression can induce any differentiation (since 
they are upregulated upon differentiation), even when the cells are left under growing 
conditions in 20% FBS medium.        
Both hsa-miR-660 and hsa-miR-532 belong to mir-188 family and their host gene is 
located in X chromosome (table3-1). Upregulation of hsa-miR-660-5p, upon 
differentiation has been reported in porcine skeletal muscle 
4
 and also in human primary 
myoblasts (5). hsa-miR-660 also shows upregulation Facioscapulohumeral muscular 
dystrophy (FSHD) as compared to normal human myoblast cells (6). However no 
function of hsa-miR-660-5p in muscle development has been described yet. So we 
wanted to investigate the role of this miRNA. hsa-miR-532-5p is also a poorly studied 
miRNA with regards to muscle biology. It is however known to be expressed in 
mesenchymal stem cells which promote tissue repair/regeneration through release of 
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growth factors, cytokines and extracellular matrix molecules (7). Repair and regeneration 
are very important aspects of muscle development.   
miRNA Genomic position / Coordinates Gene Family 
hsa-miR-139 Chr 11: 72326107 – 72326174 [-] mir - 139 
hsa-miR- 92a Chr 13: 92003568 – 92003645 [+] mir - 25 
hsa-miR-206 Chr 6: 52009147 – 52009232 [+] mir - 1 
hsa-miR- 532 chrX: 49767754 – 49767844 [+] mir – 188 
hsa-miR- 660 chrX: 49777849 – 49777945 [+] mir – 188 
 
Table 3-1: Genome context of miRNA 
 
miR-92a which is a member of mir 17-25 cluster, has recently been shown to be involved 
in post transcriptional regulation of Hand 2 gene in heart muscle (8). miR-92a has also 
been found involved some primary muscular disorders (9). But in-depth knowledge of 
role played by miR-92a in muscle development is lacking. Role of hsa-miR-139-5p 
during skeletal muscle development has also not been investigated yet. 
In this chapter I have tried to shed light on the functional impact of these miRNAs, which 
remain poorly studied and investigated in human skeletal muscle development so far.    
Experimental plan is depicted below: 
 
 
 
 
 
 
 
 
 
 
 
 
miRNA transfected 
Myoblast 
cells 
Left for 12 hours 
Left for 24 hours 
RNA seq 
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3.2 Materials and methods: 
3.2.1 Cell culture 
CHQ5B myoblast cells were cultured in 6cm petri dishes. 5.9*10
5 
cells were cultured in 
one dish. Cells were maintained in 20% FBS medium throughout.       
3.2.2 Transient transfection with oligonucleotides 
CHQ5B myoblasts were transfected with miR-206, miR-139-5p, miR-532-5p, miR-660-
5p and miR-92a-3p mirVana mimics at a 40nM concentration, or with a non-targeting 
negative control miRNA (miR-NC) oligos (Ambion) using Lipofectamine RNAiMax 
(Invitrogen) according to the manufacturer’s instructions. Transfected cells were 
harvested for in vitro studies after culturing for 12h and 24h. 
 
3.2.3 RNA extraction and Whole transcriptome sequencing 
Poly(A)
+
 RNA was extracted from the cells after 12h and 24h of transfection using 
Amersham kit (details has been mentioned in chapter I). Quality of RNA was tested using 
agilent technologies and quantified using Qbit. The mRNA was then processed for 
sequencing using manufacturer’s instructions and sequencing was performed using 
Applied biosystem’s SOLiD technology.  
Differential gene expression analysis was performed using edgeR software with a P value 
of 0.1 considered statistically significant. 
 
3.3 Results: 
3.3.1 miRNA expression upon muscle differentiation 
Upon differentiation of CHQ5B myoblasts into myotubes we found many miRNA 
differentially expressed. In details this has been discussed in chapter I. We found hsa-
miR-139-5p, hsa-miR-532-5p, hsa-miR-660-5p and hsa-miR-206 were differentially 
upregulated upon myotube formation with an FDR 0f 0.05. hsa-miR-92a-3p was 
upregulated although not differentially, but its level of expression was very high and 
prominent therefore we chose to study it. Table 3-2 shows log2 FC for each miRNA. The 
bar plot in figure 3-1 show the expression level of these miRNAs in both myoblast and 
myotubes. 
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3.3.2 Transient miRNA over expression caused higher number of genes upregulated 
and less genes down regulated 
Differentially expressed genes for each miRNA transfection were found as compared to 
negative control with an FDR of 0.1. Whole transcriptome analysis showed that, each 
miRNA over expression caused both up regulation and down regulation of several genes. 
We found that each over expression caused, higher number of genes differentially 
upregulated as compared to the number of genes down regulated for both time points of 
12 hours and 24 hours (figure 3-2).  
 
 
 
 
 
 
 
 
miRNA Log2 FC P value 
hsa-miR-139-5p 6.12 2.83E-11 
hsa-miR-532-5p 1.93 0.004881 
hsa-miR-660-5p 2.35 0.000749 
hsa-miR-92a-3p 0.96 0.152295 
hsa-miR-206 5.55 6.03E-12 
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Table 3-2: miRNA differentially upregulated 
in myotubes with their log2 fold change values 
and P-values.  
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Figure 3-1: Bar plot showing miRNA 
expression in myoblasts and 
myotubes. From this plot the 
differential upregulation of these 
miRNAs can be seen. 
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Figure 3-2: Bar plot showing gene expression after 12 and 24 hours of transfection. 139-
12H/24H = hsa-miR-139-5p transfection effect after 12h/24h, 206-12H/24H = hsa-miR-206 
transfection effect after 12h/24h, 532-12H/24H = hsa-miR-532-5p transfection effect after 
12h/24h, 660-12H/24H = hsa-miR-660-5p transfection effect after 12h/24h, 92a-12H/24H = hsa-
miR-92a-3p transfection effect after 12h/24h. The number of genes showing differential 
expression is also shown in the boxes below the bars. 
 
24 hours post transfection with miR-92a and miR-660, highest number of genes was 
found affected, and miR-660 over expression showed highest number of genes 
upregulated (table 3-3). 
miRNA Up regulated Down regulated Total genes affected 
hsa-miR-139 347 325 672 
hsa-miR- 92a 427 271 698 
hsa-miR-206 419 144 563 
hsa-miR- 532 312 75 387 
hsa-miR- 660 536 162 698 
 
Table 3-3: 24h post miRNA over expression effect. Shown are the numbers of genes up and 
down regulated for each miRNA. The last column shows the total number of genes altered after 
24 h. 
As a general expectation, far fewer genes were found affected after 12 hours of miRNA 
mimic transfection. 12 hours post transfection with miRNA-206 showed highest number 
of genes with altered expression (table 3-4).    
miRNA Up regulated Down regulated Total genes affected 
hsa-miR-139 48 15 63 
hsa-miR- 92a 11 3 14 
hsa-miR-206 153 86 239 
hsa-miR- 532 102 26 128 
hsa-miR- 660 0 2 2 
    
Table 3-4: 12h post miRNA over expression effect. Shown are the numbers of genes up and 
down regulated for each miRNA. The last column shows the total number of genes altered after 
24 h. 
 
3.3.3 Differential gene expression, Pathway and GO analysis for genes affected by 
each miRNA 
We used edgeR software for differential gene expression analysis. KEGG pathway 
database (http://www.genome.jp/kegg/pathway.html) using the Homo sapiens reference 
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pathway and DAVID online software (http://david.abcc.ncifcrf.gov) were used to 
determine the cellular pathways and biological functions that could be influenced by over 
expression of miRNAs in CHQ5B myoblast cells. The pathways and processes associated 
with altered genes for each miRNA have been discussed in details in the following 
sections.      
3.3.3a) hsa-miR-139-5p analysis 
We observed that after miR-139-5p transfection, a total of 63 and 672 genes were 
affected post 12 and 24 hours of transfection respectively. After 12 hours of transfection, 
15 snoRNA genes were found down regulated and only 48 genes were upregulated. 
Genes found most repressed and considerably over expressed after transient transfection 
have been listed in supplementary table S3-1. Targetscan database, predicts NRK, 
MYCBP and HDX as targets of miR-139-5p, which we also found were -5.55, -5.77 and -
6.06 log2 folds down regulated respectively after 24 hours. This observation is suggestive 
that these three genes might be directly repressed by miR-139-5p.   
For genes differentially regulated after 24 hours of miR-139-5p over expression, KEGG 
pathways with ≥ 7 differentially expressed genes have been listed in table 3-5, but in fact 
many more pathways were detected by KEGG. The 7 pathways with at least 7 
differentially expressed genes are listed along with their log FC values.  
 
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways 
(28) 
ALDH4A1 (-6.38), ALG9 (5.42), AOC3(-6.76), ARG2(6.62), 
ATP6V1E2(5.77), B3GALNT1(-4.42), B4GALT6(5.39), BDH1(-5.91), 
CBR3(6.64), CDA(5.48), COQ2(4.89), COQ3(-6.30),  COX6A1(-4.39), 
DCXR(5.61),  GCLC(5.24), HSD11B1(2.99), MGAM(-5.37), 
NDUFA9(6.62), NDUFS6(4.41), PAFAH2(6.55), PIGH(-5.49), PIGV(5.56), 
POLR3K(5.24), PPT2(5.61), PTGDS(5.18), SHMT1(-5.37), UPRT(5.77), 
ZNRD1(5.56) 
hsa04151 PI3K-Akt signaling 
pathway (10) 
CCNE1(6.19), COL11A2 (5.70), CSF3 (5.73), FGF16 (-5.49), IGF1(5.39), 
ITGA8(-5.61), LPAR6(6.19), NGFR(-3.93), PKN3(-5.77), TLR4(5.73)  
hsa05203 Viral carcinogenesis 
(9) 
C3 (8.26), CCNE1(6.19), CDKN2A (5.94), HIST1H2BF (5.39), HIST1F2BJ 
(5.33), HIST1H2BN (5.84), HIST1H4E (5.50), KAT2B (5.42), LYN (-5.33) 
hsa04062 Chemokine 
signaling pathway (7) 
ADCY4 (4.78), CXCL3(6.45), CXCL5(6.73), CXCL6(4.18), GRK5(4.75), 
ITK(-5.88), LYN(-5.33) 
hsa05016 Huntington's disease BBC3(5.98), COX6A1(-4.39), NDUFA9(6.62), NDUFS6 (4.41), PPARG(-
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(7) 6.33), SLC25A4(6.00), TFAM (5.96) 
hsa05322 Systemic lupus 
erythematosus (7) 
C3(8.26), C4A (-5.84), C4B(-5.40), HIST1H2BF(5.39), HIST1H2BJ(5.33), 
HIST1H2BN(5.84), HIST1H4E(5.50) 
hsa05133 Pertussis (7) C3(8.26), C4A (-5.84), C4B(-5.40), CXCL5 (6.73), CXCL6(4.18), NOD1 
(5.68), TLR4 (5.73) 
 
Table3-5: KEGG pathways for genes found altered after 24 hours of hsa-miR-139-5p over 
expression. The table shows the pathway names along with the genes involved. The LHS column 
gives the pathway names with the number of genes involved mentioned with in the brackets.  In 
the RHS column, in bracket the log2 Fold change values of corresponding genes are shown. 
Values in negative show down regulation and vice versa. 
 
Pathway and gene ontology analysis shows that hsa-miR-139-5p over expression after 24 
hours, might influence genes involved in metabolism, PIK3-Akt signalling (which 
regulates fundamental cellular functions such as transcription, translation, proliferation, 
growth and survival), viral carcinogenesis, chemokine signalling, transcription regulation 
and chemokine activity. However, after 12 hours hsa-miR-139-5p seems to affect 
biological processes of regulation of coagulation, regulation of response to stimulus and 
cellular response to stress. (supplementary table S3-6).      
3.3.3b) hsa-miR-532-5p analysis     
128 and 327 genes were found altered after 12 and 24 hours of miR-532 over expression. 
Most prominently affected genes are listed in supplementary table S3-2. After 12 hours 
only some snoRNAs were found down regulated but no protein coding genes were turned 
down.  
For genes differentially regulated after 24 hours of miR-139-5p over expression, KEGG 
pathways with ≥ 6 differentially expressed genes have been listed in table 3-6. The 7 
pathways with at least 6 differentially expressed genes are listed along with their log FC 
values.  
24 HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways (18) ALG10(5.32), ALG9(5.65), AOC3(-6.48), BPGM(5.86), 
CBR3(4.52), COX7B(5.50), CYP2R1(5.21), GALNT12(4.27), 
GCLC(6.01), IDI1(6.47), NDUFA9(5.65), NDUFS6(4.24), 
PAFAH2(4.74), PIGV(4.77), POLR3F(5.21), QPRT (-4.07), 
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SDHD(4.07), TH(-4.83) 
hsa05203 Viral carcinogenesis (7) C3(6.56), CCNE1(5.62), CDKN2A(5.43), HIST1H2BD(4.93), 
HIST1H4E(6.28), KAT2B(5.21), REL(5.62) 
hsa04060 Cytokine-cytokine receptor 
interaction (7) 
ACVR2A(5.62), CXCL1(5.04), CXCL3(5.04), CXCL5(5.05), 
CXCL6(4.82), EGF(5.36), IL15 (5.17) 
hsa05016 Huntington's disease (7) BBC3(3.49), COX7B(5.50), NDUFA9(5.65), NDUFS6(4.24), 
SDHD(4.07), SLC25A4(5.04), TFAM(5.65) 
hsa05012 Parkinson's disease (6) COX7B(5.50), NDUFA9(5.65), NDUFS6(4.24), SDHD(4.07), 
SLC25A4(5.04), TH(-4.83) 
hsa04062 Chemokine signaling pathway 
(6)  
CXCL1(5.04), CXCL3(5.04), CXCL5(5.05), CXCL6(4.82), 
GRK5(5.56), ITK(-5.60) 
12HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways (10) ALG9(5.86), CBR3(5.70), DCXR(5.88), FUT4(5.91), 
IDI1(4.56), NDUFA9(5.53), PAFAH2(6.07), POLR3F(5.76), 
PTGS2(4.24), UPRT(5.93) 
 
Table3-6: KEGG pathways for genes found altered after 12 and 24 hours of hsa-miR-532-5p 
over expression. The table shows the pathway names along with the genes involved. The LHS 
column gives the pathway names with the number of genes involved mentioned with in the 
brackets.  In the RHS column, in bracket the log2 Fold change values of corresponding genes are 
shown. Values in negative show down regulation and vice versa. 
 
Genes for almost 22 zinc finger proteins, myosin heavy chain 15 (MYH15), some histone 
cluster protein and chemokine ligand were upregulated after 24 hours of miR-532-5p over 
expression.       
Pathway and gene ontology analysis shows that hsa-miR-532-5p over expression after 24 
hours, might influence (both by up regulating and down regulating) genes involved in 
metabolism, viral carcinogenesis, cytokine-cytokine receptor interaction, regulation of 
transcription, chemokine activity, response to hypoxia. However, after 12 hours hsa-miR-
532-5p seems to affect along with metabolic pathways, biological processes of regulation 
of coagulation, regulation of response to stimulus and cellular response to stress. 
(supplementary table S3-7). 
3.3.3c) hsa-miR-660-5p analysis 
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We observed that after 12 hours of miR-660-5p transfection, no alteration to gene 
expression was caused. Only 2 genes were down regulated after 12 hours. However 24 
hours post-transfection, 698 genes showed differential expression. Thereby, indicating 
that miR-660-5p probably takes a gradual course of action into the cells, as compared to 
other miRNAs which we have studied. Supplementary Table S3-3 lists the genes found 
most significantly influenced by miR-660-5p over expression.   
For genes differentially regulated after 24 hours of miR-660-5p over expression, KEGG 
pathways with ≥ 6 differentially expressed genes have been listed in table 3-7. The 
pathways with at least 6 differentially expressed genes are listed along with their log FC 
values.  
 
24 HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways 
(27)  
AGMAT(-4.54), ALG14(4.80), ALG9(5.67), AOC3(-3.43), CBR3(6.23), 
COX10(4.00), COX7B(4.34), CYP2R1(5.99), DCXR(6.09), FUT4(5.73), 
GCLC(6.36), MCAT(4.69), NDUFA9(4.55), NDUFS6(4.71), 
PAFAH2(6.56), PIGP(5.63), PIGV(4.48), POLR3K(5.57), PPT2(5.27), 
SDHD(3.84), SLC27A5(-4.31), SMPD2(4.30), SORD(-4.60), SPR(-
3.41), TPK1(-5.47), UPRT(5.42), ZNRD1(4.85) 
hsa05203 Viral carcinogenesis 
(9)  
C3(5.49), CCNE1(5.70), CDKN2A(5.85), HIST1H2BD(5.30), 
HIST1H2BN(5.07), HIST1H4A(4.97), IRF9(4.91), KAT2B(5.85), 
REL(5.46) 
hsa05016 Huntington's disease 
(7) 
BBC3, COX7B, NDUFA9(4.55), NDUFS6(4.71), SDHD(3.84), 
SLC25A4, TFAM(5.99) 
hsa04151 PI3K-Akt signaling 
(7) 
CCNE1(5.70), FGF16(-5.03), NGF(4.74), PPP2R2B(5.67), 
PPP2R5A(3.37), TLR4(5.99), VWF(-4.66) 
hsa05200 Pathways in cancer 
(7) 
AXIN2(-3.58), CCNE1(5.70), CDKN2A(5.85), FGF16(-5.03), FLT3LG(-
4.50), LEF1(5.38), MITF(5.02) 
hsa05012 Parkinson's disease 
(6) 
COX7B(4.34), NDUFA9(4.55), NDUFS6(4.71), SDHD(3.84), 
SLC25A44.74), SNCAIP(5.34) 
hsa03010 Ribosome (6) FAU(3.84), MRPS14(5.41), RPL18A(3.79), RPL41(4.55), RPS26(5.02), 
RPS7(3.54) 
hsa05010 Alzheimer's disease 
(6) 
APH1B(3.47), CASP7(-5.93), COX7B(4.34), NDUFA9(4.55), 
NDUFS6(4.71), SDHD(3.84) 
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Table3-7: KEGG pathways for genes found altered after 24 hours of hsa-miR-660-5p over 
expression. The table shows the pathway names along with the genes involved. The LHS column 
gives the pathway names with the number of genes involved mentioned with in the brackets.  In 
the RHS column, in bracket the log2 Fold change values of corresponding genes are shown. 
Values in negative show down regulation and vice versa. 
 
Pathway and gene ontology analysis shows that hsa-miR-660-5p over expression after 24 
hours, might influence (both by up regulating and down regulating) genes involved in 
metabolism, viral carcinogenesis, Huntington disease, PI3K-Akt pathway, regulation of 
transcription, regulation of cell death and regulation of apoptosis (supplementary table 
S3-8). hsa-miR-660-5p caused many zinc finger proteins upregulated after 24 hours, and 
GO analysis indicate the positive effect miR-660-5p has on transcriptional regulation of 
CHQ5B myoblast cells.  
3.3.3d) hsa-miR-92a-3p analysis 
Like hsa-miR-660-5p, has-miR-92a-3p also showed very little near negligible effect on 
transcriptome after 12 hours as only 14 were found affected but after 24 hours of miRNA 
over expression 698 genes showed differential expression. Genes found most affected 
after 12 and 24 hours of miRNA over expression have been listed in table S3-4. 
For genes differentially regulated after 24 hours of miR-92a-3p over expression, KEGG 
pathways with ≥ 8 differentially expressed genes have been listed in table 3-8. The 7 
pathways with at least 6 differentially expressed genes are listed along with their log FC 
values. 
 
24 HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways (27)  AKR1B10(-4.81), ALG10(5.09), ALG3(-4.43), 
ALG9(6.78), ATP6V1E2(5.39), ATP6V1G1(-4.25), 
BPGM(4.20), COX6A1(-4.70), CTH(6.00), 
CYP2R1(5.66), FUK(-5.99), GALNT12(5.87), 
GCLC(5.92), ISYNA1(-5.52), MCEE(-5.47), 
NDUFAB1(-5.52), NDUFS6(4.90), PAFAH2(5.87), 
PIGL(-5.79), PIGV(4.34), POLR3F(4.78), 
POLR3K(5.35),  ST3GAL6(5.46), TGDS(-4.81), TPK1(-
5.54), UPRT(5.75),  ZNRD1(6.27) 
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hsa05203 Viral carcinogenesis (17) BAK1(-5.65), C3(8.55), CCNE1(5.35), CDKN2A(5.75), 
GTF2B(3.84), HIST1H2BC(6.04), HIST1H2BJ(5.09), 
HIST1H4E(4.72), HLA-F(4.45), HLA-G(5.87), 
IRF9(6.07), KAT2B(5.46), LYN(-5.40), POLB(-5.56), 
RBL1(-5.69), REL(6.20) 
hsa04060 Cytokine-cytokine receptor 
interaction (9)  
CSF3(7.14), CXCL1(3.71), CXCL3(5.23), CXCL5(5.44), 
CXCL6(4.54), IL10RB(-5.03), IL15(5.84), 
TNFSF12(5.57), TNFSF4(-5.38) 
hsa04510 Focal adhesion (9) BCL2(6.20), BIRC3(5.18), CAV3(-5.52), 
COL11A2(5.09), IGF1(5.72), ITGA8(-6.13), 
LAMB3(3.74), MYLK2(-6.03), PAK3(5.35) 
hsa05166 HTLV-I infection (8) ADCY4(5.10), CDKN2A(5.75), HLA-F(4.45), HLA-
G(5.87), IL15(5.84), KAT2B(5.46), POLB(-5.56), 
SLC25A4(6.00) 
hsa04062 Chemokine signaling pathway (8) ADCY4(5.10), CXCL1(3.71), CXCL3(5.23), 
CXCL5(5.44), CXCL6(4.54), GRK5(4.31), ITK(-5.50), 
LYN(-5.40) 
 
Table3-8: KEGG pathways for genes found altered after 24 hours of hsa-miR-92a-3p over 
expression. The table shows the pathway names along with the genes involved. The LHS column 
gives the pathway names with the number of genes involved mentioned with in the brackets.  In 
the RHS column, in bracket the log2 Fold change values of corresponding genes are shown. 
Values in negative show down regulation and vice versa. 
Pathway and gene ontology analysis shows that hsa-miR-92a-3p over expression after 24 
hours, might influence (both by up regulating and down regulating) genes involved in 
metabolic pathways, viral carcinogenesis, cytokine-cytokine receptor interaction, focal 
adhesion, regulation of transcription, mitochondrial transport, protein targeting to 
mitochondrion and mitochondrion organization (supplementary table S3-9.).     
3.3.3e) hsa-miR-206 analysis (Positive control) 
Compared to rest of the miRNAs, hsa-miR-206 showed highest genes having changed 
their expression after 12 hours, with 239 genes found influenced. After 24 hours of 
miRNA over expression 563 genes showed altered expression. Genes most prominently 
influenced are shown in tableS3-5.  
For genes differentially regulated after 24 hours of miR-206 over expression, KEGG 
pathways with ≥ 8 differentially expressed genes have been listed in table 3-9. The 7 
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pathways with at least 6 differentially expressed genes are listed along with their log FC 
values. 
 
24 HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways (21) 
 
ALG9(5.04), AOC3(-5.35), CDA(4.99), CKM(5.48), 
COX10(4.90),CYP2R1(2.50), DCXR (5.96), GALNT3 (5.55), 
GCLC(5.82), GK(5.19), IDI1(3.69), NDUFA9(5.61), 
PAFAH2(5.76), PIGH(-4.08), POLR3F(5.51), POLR3K(6.04), 
PPT2(4.58), PYGM(4.99), SMPD2(5.11), UPRT(6.28), 
ZNRD1(6.38) 
hsa05203 Viral carcinogenesis (8) 
 
C3(7.09), CASP8(-3.52), CCNE1(5.19), CCNE2(6.28), 
CDKN2A(6.09), KAT2B(5.19), LYN(-4.38),REL(5.04) 
hsa05200 Pathways in cancer  (8) 
 
CASP8(-3.52), CCNE1(5.19), CCNE2(6.28), CDKN2A(6.09), 
FGF16,PPARG,TGFB2(3.72), WNT3(5.28) 
hsa05166 HTLV-I infection  (7) 
 
ADCY4(4.02), CDKN2A(6.09), CHEK2(-4.80), KAT2B(5.19), 
SLC25A4(5.04), TGFB2(3.72), WNT3(5.28) 
hsa04110 Cell cycle (7) 
 
CCNE1(5.19), CCNE2(6.28), CDC14A(6.57), CDK7(5.02), 
CDKN2A(6.09), CHEK2(-4.80), TGFB2(3.72) 
hsa04151 PI3K-Akt signaling pathway 
(7) 
 
CCNE1(5.19), CCNE2(6.28), CSF3(5.04), FGF16(-4.08), 
PPP2R2B(6.04), SGK3(4.75), TLR4(4.99) 
hsa04020 Calcium signaling pathway 
(7) 
 
ADCY4(4.02), CACNA1H(5.04), CHRM3(5.48), PTGER3(5.19), 
SLC25A4(5.04), TBXA2R(5.48), TNNC2(5.28) 
12 HOURS  
KEGG Pathways Differentially expressed genes (with their log FC) 
hsa01100 Metabolic pathways (13) 
 
ALG9(5.45), CBR3(6.00), COX7B(4.65), GALNT3(5.58), 
GCLC(6.21), IDI1(4.40), NDUFS6(5.04), PAFAH2(6.25), 
POLR3F(5.07), PTGS2(3.98), QPRT(-5.35), TPK1(-5.65), 
ZNRD1(5.42) 
hsa04151 PI3K-Akt signaling pathway 
(5) 
 
CCNE1(5.45), CCNE2(5.72), COL11A2(5.61), JAK3(-5.22), 
TLR4(6.07) 
hsa05203 Viral carcinogenesis (5) 
 
C3(6.27), CCNE1(5.45), CCNE2(5.72), HIST1H2BC(5.42), 
JAK3(-5.22) 
 
Table3-9: KEGG pathways for genes found altered after 12 and 24 hours of hsa-miR-206  over 
expression. The table shows the pathway names along with the genes involved. The LHS column 
gives the pathway names with the number of genes involved mentioned with in the brackets.  In 
the RHS column, in bracket the log2 Fold change values of corresponding genes are shown. 
Values in negative show down regulation and vice versa. 
67 
 
GO analysis for genes turned up after 12 hours showed that biological process terms of 
positive regulation of smooth muscle contraction, muscle contraction and BP terms of 
transcription, transcription regulation, muscle contraction were enriched for genes turned 
up after 24 hours (supplementary table S 3-10).  
hsa-miR-206 has a very well documented role in muscle developmental biology. With our 
transient over expression studies, we found out the repertoire of genes which got effected 
by the over expression of this miRNA for 12 and 24 hours. Genes which were over 
expressed at 12 hours, showed enrichment for biological processes specific for muscle 
development like, positive regulation of muscle contraction, positive regulation of smooth 
muscle contraction, electron transport chain. This result stands in parallel to the well-
established involvement of miR-206 in muscle development, as the over expression of 
miRNA enhanced muscle developmental processes.  
3.3.4 Common effects exerted by all miRNAs    
We observed that number of genes with altered expression after 12 hours of transfection 
were considerably low than those affected after 24 hours for each miRNA, as shown in 
the bar graph of figure 3-3.  
Genes down regulated after 12 hours of each miRNA over expression were mostly 
snoRNAs, as shown in the pie chart (figure 3-4 A). A greater percentage of over 
expressed genes were protein coding, others were either non protein coding genes or 
genes coding for uncharacterized proteins. The bar plot (figure 3-4 D) shows the %age of 
protein coding genes among all over expressed genes. 
We were interested to find if there are any genes commonly perturbed by two or more 
miRNA of all the five miRNAs we have investigated. We found that almost ¼ th of the 
total genes upregulated after 24 hours of each miRNA over expression, were commonly 
affected by either all five miRNA or by any two miRNAs (figure3-4 B). The genes which 
are affected by only any one miRNA largely comprised of non-coding genes. The 
observation remained almost similar for genes down regulated after 24 hours (figure3-4 
C). Since very limited number of genes was differentially affected after 12 hours, we 
focused on results of 24 hour transfection to find out common affect exerted by all the 
miRNAs together.    
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We also looked for genes which remained either supressed or over expressed through 12h 
and 24h. We found limited number of genes remained common between both time points 
for each miRNA. 
 
 
 
 
 
 
 
 
Figure3-3: Bar plot comparing the effect on gene expression after 12h and 24h of miRNA over 
expression. X-axis gives the number of genes altered and y-axis gives the name of miRNA.  
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Figure3-4: (A) Pie chart showing percentage of snoRNA amongst total genes down regulated 
after 12 hours of miRNA over expression. (B) Doughnut plot representing proportion of 
upregulated genes, commonly perturbed by more than one miRNA. (C) Doughnut plot 
representing proportion of downregulated genes, commonly perturbed by more than one 
miRNA.(D) Percentage of protein coding genes amongst up regulated after 24h of miRNA over 
expression. 139-24H = hsa-miR-139-5p transfection effect after 24h, 206-24H = hsa-miR-206 
transfection effect after 24h, 532-24H = hsa-miR-532-5p transfection effect after 24h, 660-24H = 
hsa-miR-660-5p transfection effect after 12h/24h, 92a-24H = hsa-miR-92a-3p transfection effect 
after 24h. 
3.3.5 Comparison of miR down regulated genes with Ago2 enriched genes in 
myoblasts 
In the previous chapter, I have described the genes enriched with Ago2 pull down. Here I 
have compared the genes down regulated by each miRNA after 24 hours with the genes 
enriched with Ago2 in myoblasts. We found some genes common and they are listed in 
table 3-10. 
 
miRNA Genes down 
regulated  
Protein encoded and function 
hsa-miR-139-5p GYG2 Encodes the muscle glycogenin. Glycogenin is a self-
glucosylating protein involved in the initiation reactions of 
glycogen biosynthesis.  
 MYH7 Myosins are a large family of motor proteins that share the 
common features of ATP hydrolysis, actin binding and 
potential for kinetic energy transduction. 
 COBL Plays an important role in the reorganization of the actin 
cytoskeleton. 
 CDK18 May play a role in signal transduction cascades in terminally 
differentiated cells 
 HRC May play a role in the regulation of calcium sequestration or 
release in the SR of skeletal and cardiac muscle 
 MYBPH Binds to myosin; probably involved in interaction with thick 
myofilaments in the A-band 
 139-24H 206-24H 532-24H 660-24H 92a-24H
78
56
67
54
61
% Protein coding
D 
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 SHF Adapter protein which may play a role in the regulation of 
apoptosis in response to PDGF 
 HES6 This gene encodes a member of a subfamily of basic helix-
loop-helix transcription repressors.  Members of this gene 
family regulate cell differentiation in numerous cell types. 
 AQP3 Acts as a glycerol transporter in skin 
 VGLL2 May act as a specific coactivator for the mammalian TEFs. 
May play a role in the development of skeletal muscles 
 MSC Transcription repressor capable of inhibiting the transactivation 
capability of TCF3/E47. May play a role in regulating antigen-
dependent B-cell differentiation 
 MYLPF myosin light chain, phosphorylatable, fast skeletal muscle 
 CAV3 regulate voltage-gated potassium channels. Plays a role in the 
sarcolemma repair mechanism of both skeletal muscle and 
cardiomyocytes that permits rapid resealing of membranes 
disrupted by mechanical stress 
hsa-miR-532-5p COBL Plays an important role in the reorganization of the actin 
cytoskeleton. 
 GMPR Catalyzes the irreversible NADPH-dependent deamination of 
GMP to IMP. It functions in the conversion of nucleobase, 
nucleoside and nucleotide derivatives of G to A nucleotides, 
and in maintaining the intracellular balance of A and G 
nucleotides 
 LMOD3 GO annotations related to this gene include tropomyosin 
binding. An important paralog of this gene is TMOD1. 
hsa-miR-660-5p LMOD3 GO annotations related to this gene include tropomyosin 
binding. An important paralog of this gene is TMOD1. 
 ARPP21 Isoform 2 may act as a competitive inhibitor of calmodulin-
dependent enzymes such as calcineurin in neurons 
hsa-miR-92a-3p COBL Plays an important role in the reorganization of the actin 
cytoskeleton. 
 CDK18 May play a role in signal transduction cascades in terminally 
differentiated cells 
 SHF Adapter protein which may play a role in the regulation of 
apoptosis in response to PDGF 
 VGLL2 May act as a specific coactivator for the mammalian TEFs. 
May play a role in the development of skeletal muscles. 
 UCP2 UCP are mitochondrial transporter proteins that create proton 
leaks across the inner mitochondrial membrane, thus 
uncoupling oxidative phosphorylation from ATP synthesis. As 
a result, energy is dissipated in the form of heat 
 CAV3 regulate voltage-gated potassium channels. Plays a role in the 
sarcolemma repair mechanism of both skeletal muscle and 
cardiomyocytes that permits rapid resealing of membranes 
disrupted by mechanical stress 
hsa-miR-206 HRC May play a role in the regulation of calcium sequestration or 
release in the SR of skeletal and cardiac muscle 
 SHF Adapter protein which may play a role in the regulation of 
apoptosis in response to PDGF 
 AQP3 Acts as a glycerol transporter in skin 
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Table 3-10: Genes down regulated by miRNA and enriched in Ago2 pull down. The gene names 
and the function of proteins encoded by them (taken from Gene cards) have been shown in 
corresponding columns. 
With this analysis we found that hsa-miR-139-5p turns down genes like MYH7, MYBPH, 
MYLPF, CAV3 and CDK 18 which are upregulated on myotube formation as they have 
muscle specific roles. hsa-miR-532-5p caused down regulation of LMOD3 gene which 
binds to tropomyosin.  hsa-miR-660-5p also inhibits LMOD3 gene. hsa-miR-92a-3p is 
found to bring under expression of COBL, CDK18, SHF, VGLL2, UCP2 and CAV3 
genes all of which have muscle related functions. hsa-miR-206 inhibited or down 
regulated HRC genes. 
These results indicate that although they are turned up in myotubes, but in myoblasts they 
have a role to keep down the expression of genes which have role in muscle 
differentiation.  
3.4 Discussion: 
In this chapter I have tried to elucidate, the overall impact of hsa-miR-139-5p, hsa-miR-
532-5p, hsa-miR-660-5p, hsa-miR-92a-3p and hsa-miR-206 over expression on the 
transcriptome of human skeletal myoblast cells. We chose to study these miRNA as we 
found them significantly upregulated upon differentiation into myotubes. Also these 
remain very little studied in human skeletal muscle. Our goal was not to study the target 
genes specifically, but to find out the overall affect these miRNA have on skeletal muscle 
development. The direct effect of one miRNA on a cell might be limited, but that little 
impact actually is far wider at the molecular level, as the message gets conveyed from one 
molecule to another. So, we considered studying the total impact at molecular level which 
these miRNA have on the muscle cells. We chose to do the analysis of gene expression at 
two time points of 12h and 24h post miRNA over expression to verify if the impact of 
perturbation on transcriptome remains steady or changes with time.    
The rationale of these experiments was based on the observation that some miRNAs are 
found at a much higher level after differentiation of myoblasts into myotubes. Therefore, 
the impact of each miRNA on gene regulation could be “dissected” by overexpressing it 
in myoblasts and looking of the effect on the transcriptome. One of our  
presumptions was that the over expression of some miRNAs could induce differentiation 
of transfected myoblast cells (as these miRNA are upregulated upon muscle 
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differentiation). However with the transcriptomic analysis that is not what we found.  On 
comparing the genes down regulated by each miRNA with the genes enriched with Ago2 
pull down in myoblasts we found some common genes. These genes have muscle specific 
function. So we found that although these miRNAs are turned up upon differentiation, 
when they are over expressed in myoblast they do not induce differentiation, rather they 
keep down genes which have a role in muscle development and differentiation. We can 
infer that since from the surrounding (which has 20%FBS) the cells do not get the 
message to undergo differentiation and mere upregulation of these miRNA was not a 
strong trigger for the cells to differentiate. This also shows that even though they are 
expressed at a much lower level in myoblasts, they still have a role in maintaining the 
proliferative state of the cells, by keeping down genes involved in muscle differentiation.  
Also, with each miRNA transfection we observed greater number of genes upregulated 
than genes down regulated at both the time points of 12 and 24 hours. This finding of ours 
goes very much in accordance with the review by Shobha Vasudevan, which talks about 
the post transcriptional upregulation by miRNA (10). Also, recent research is showing the 
role of miRNA in upregulation of genes (11,12,13). These findings make it more concrete 
that miRNA have role in over expression of mRNA and not only in turning down gene 
expression. It is difficult for us to ascertain if the genes found up regulated were directly 
acted upon by the miRNA or whether what we observed was an implied effect, but it is 
possible that there may be a direct effect of the miRNAs. Our whole transcriptome 
analysis showed that, with each miRNA transfection and at both the time points of 12h 
and 24h, higher numbers of genes were differentially turned up as compared to the total 
number of genes differentially down regulated. This stands contradictory to the more 
widely accepted concept for any miRNA, which is to down regulate genes. We however 
do not know if prolonged time periods of observation would have changed the picture by 
turning down more genes and less genes over expressed. We observed that total number 
of genes altered after miRNA over expression escalated at 24 hours as compared to 12 
hours, also very limited genes remained either over or under expressed throughout 12 – 
24 hours, indicating that miRNA takes a gradual course of action inside the cells and the 
effect changes with time. After 12h the overall change in protein coding gene expression 
was very little to discern any biological meaning from them. So, our findings mainly 
come from 24h time point.  
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With pathway analysis for genes with altered expressions, we found that metabolic 
pathways were majorly and consistently influenced by each miRNA over expression. 
Also, genes over expressed after 24 hours of miRNA transfection were mainly involved 
in biological process of transcription and transcriptional regulation. Genes over expressed 
after hsa-miR-92a showed enrichment of “response to wounding” along with 
transcriptional regulation. hsa-miR-206 is very well characterised for its role in muscle 
development (1,2,3), we used it as a positive control for our experiment. We found that 
genes over expressed after 12h and 24h of miR-206 over expression were enriched for 
biological process terms of positive regulation of muscle contraction, positive regulation 
of smooth muscle contraction, heart contraction, muscle contraction etc. This is a good 
evidence to show reliability of our experiment and its results. But the interesting part is 
that genes “upregulated” were enriched for muscle specific function terms after miR-206 
over expression. This finding of our’s indicates that miRNA causes upregulation of genes. 
The set of genes perturbed due to miRNA over expression was different for each miRNA, 
but their over-all effect remained quite similar to an appreciable extent.  
Our main finding from this experiment are: (1) Each of the 5 miRNAs caused more genes 
turned up as compared to turned down after 12h and 24h of over expression, we however 
cannot comment how many of these genes were directly affected and how many came out 
as a secondary effect. (2) After 24hours, genes turned up by each miRNA were involved 
on biological process of transcriptional regulation and transcription. Except for miR-206, 
which showed enrichment of muscle specific processes. (3) Metabolic pathways mainly 
and consistently were perturbed due to each miRNA over expression. (4) With the 
comprehensive analysis for all the 5 miRNAs, we find that they all participate towards 
transcriptional regulation. But we did not see the transcriptome of myoblasts shifting 
towards myotubes after miRNA perturbation, except for hsa-miR-206 which is a well-
documented miRNA in muscle development and we used it as a positive control for our 
study. (5) Comparison analysis of genes down regulated by these miRNA after 24h with 
Ago2 enriched genes in myoblasts showed some common genes. We found these genes 
were involved in muscle differentiation and development. Hence it shows that although 
these miRNA are less expressed in myoblasts, they still have a role to play in maintaining 
the cell proliferation by preventing upregulation of genes for muscle development. Mere 
upregulation of miRNA did not cause the cells to differentiate.  
3.5 Reference 
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Chapter - 4 
 
Whole transcriptome analysis of 
differentiation of human skeletal 
muscle cells on three-dimensional 
scaffold 
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This work was performed in collaboration with Professor Nicola Elvassore of 
“Dipartimento Di Ingegneria Industriale, Universita Degli Studi di Padova”. The work 
was carried out with Susi Zatti, a then PhD student who worked with Prof. Elvassore. 
This work was undertaken mainly as an interest of prof. Elvassore to test the influence of 
3D hydrogel matrix on human skeletal muscle cells. Our interest was to elucidate the 
influence 3D culture exerts on the transcriptome of skeletal muscle cells.  
With the next generation sequencing facility in our lab we performed the RNA seq of 
muscle cells grown in 3D culture. The RNA seq result analysis was also performed by us. 
The cell culture and immunofluorescence of cells in 3D culture were performed in the 
Dipartimento Di Ingegneria Industriale. CHQ5B cells were used for this experiment.            
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4.1 Introduction:   
Myogenesis is the formation of muscular tissue, particularly during embryonic 
cevelopment. Muscle fibers form from the fusion of myoblasts into multi-nucleated fibers 
called myotubes. In the early development of an embryo these myoblasts will proliferate 
if enough fibroblast growth factor (FGF) is present. Whne the FGF runs out, the 
myoblasts cease division and secrete fibronectin onto extracellular matrix. The second 
stage involves the alignment of the myoblasts into the myotubes. The third stage is the 
actual cell fusion itself. In this stage, calcium ions are critical for development. Fusion is 
mediated by a set of metalloproteinases called meltrins. Myocyte enhancer factors 
(MEFs) promote myogenesis. 
It is known that cells as classical 2D cultures loose many of the hallmarks of their in vivo 
counterparts. In 2D cell culture, cells are grown on flat dishes made of polystyrene plastic 
that is very stiff and unnatural. 3D cell-culture models have recently garnered great 
attention because they often promote levels of cell differentiation and tissue organization 
not possible in conventional 2D culture systems. In 3D cell culture, cells attach to one 
another and form natural cell-to-cell attachments. The cells and the extracellular matrix 
that they synthesize and secrete in three dimensions is the natural material to which cells 
are attached. It is flexible and pliable like natural tissues. It is made of complex proteins 
in their native configuration and so provides important biological instructions to the cells. 
In this 3D cell culture environment, cells can exert forces on one another and can move 
and migrate as they do in vivo. The close proximity of cells in 3D also enables surface 
adhesion molecules and surface receptors on one cell to bind to surface adhesion 
molecules and surface receptors on an adjacent cell. This coupling in 3D also maximizes 
cell-to-cell communication and signaling that is critical for cell function. Not too 
surprising, the phenotype or function of cells grown in 3D is more complex and closer to 
the functions of native tissues than cells grown in 2D (1, 27).  
Since cells grown in vitro are dramatically perturbed by their micro environment, genome 
wide gene expression analysis is of paramount importance, as it provides the insight of 
genes and pathways affected in cells as compared to their tissue of origin. We have 
performed the transcriptome analyses of human skeletal muscle cells grown in 2D and 3D 
culture models along with adult skeletal muscle tissue and identified differentially 
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expressed genes, to develop a better understanding of how the cells adapt to in vitro 
microenvironments.      
4.2. Materials and Methods 
4.2.1 Cell Culture  
Human primary skeletal muscle cells (CHQ5B):  
CHQ5B primary human myoblasts were kindly provided by Dr. V. Mouly (URA, CNRS, 
Paris, France). CHQ5B human myoblasts were isolated from the quadriceps of a newborn 
(5 days post-natal) without any sign of neuromuscular disorders and the protocols used 
for this work were in full agreement with the current legislation on ethical rules. These 
cells can achieve 55-60 divisions before reaching proliferative senescence. 
Growth conditions: DMEM (Gibco - Invitrogen) supplemented with 20% Fetal Bovine 
Serum (Gibco, Life Technologies) and 50µg/ml gentamycin.  
Differentiation conditions: DMEM supplemented with 2% horse serum (GibcoBRL) and 
50µg/ml gentamycin.  
Differentiation of myoblasts into myotubes has to be induced by serum withdrawal when  
the myoblasts are just below confluency.. Myotube formation can be observed after two 
days after serum withdrawal.  
2D culture was carried out in 10cm petri dishes. For 3D culture of cells, at day 0 cells 
were initially suspended in matrigel 50% (v/v in DMEM) and injected inside the µ-
channels (about 2x10
4
 cells / channel). 24 hours after injection, the differentiation 
medium was added and myoblasts began to fuse forming bundles of myotubes. 3D culture 
was performed at the DIPIC (Engineering Department, University of Padova).  
 
4.2.2 RNA extraction   
4.2.2a Poly (A)
+
 RNA from CHQ5B cells in 2D culture: 
Polyadenylated RNA was extracted directly from cells using QuickPrep micro mRNA 
purification kit (Amersham Biosciences). Cells were scraped and collected after PBS 
washing, snap frozen in dry ice and stored at -80°C until use. 400µl extraction buffer 
(buffered aqueous solution containing guanidium thiocyanate and N-lauroyl sarcosine) 
was added to the pelleted cells which were  vortexed until homogenous suspension was 
achieved. This suspension was diluted with 800 µl of elution buffer (10mM Tris HCl, pH 
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7.5, 1mM EDTA) and mixed using the vortex. The mixture was centrifuged at 12,000g 
for 1 minute and the clear cellular homogenate was added to the Oligo(dT) beads 
(25mg/ml oligo dT cellulose suspended in buffer) pellet. Cellular homogenate and oligo 
(dT) beads were incubated together for 5 minutes at 70 -75 °C. This causes the 
denaturation of RNA and enhances the binding of the poly (A) tail of RNA with the oligo 
dT beads. The sample was incubated at room temperature for 30 minutes with gentle 
agitation. The supernatant was removed by centrifugation at 12,000g for 30 seconds. The 
oligo (dT) cellulose pellet was washed 4 times using high salt buffer (10mM TrisHCl, pH 
7.5, 1mM EDTA, 0.5M NaCl) followed by washing with low salt buffer (10mM TrisHCl, 
pH 7.5, 1mM EDTA, 0.1M NaCl) for another 4 times. High salt conditions allow the 
annealing of the poly(A) tail to the oligo d(T). The low salt buffer removes the poly(A)- 
RNAs (eg. tRNA and rRNA). These washings also remove contaminating DNA, RNA 
proteins. The oligo dT beads were transferred to the microspin column (polypropylene 
mini-columns) and suspended in pre heated 100 -200 µl elution buffer (10mM Tris HCl, 
pH 7.5, 1mM EDTA) or preheated RNase free water (Sigma) which releases the poly(A)
+
 
RNA and the tube was centrifuged at 12,000g for 30 seconds. The eluate contained poly 
(A) RNA which was stored at -80°C until downstream processing. 
 
4.2.2b Poly (A)
+
 RNA from CHQ5B cells in 3D culture: 
Cells were collected from 3D hydrogel matrix in extraction buffer of QuickPrep micro 
mRNA purification kit (Amersham Biosciences) after cutting open the matrix channels 
under sterile conditions. Poly(A) RNA was extracted was carried out using the same 
procedure as mentioned in section 3.2.2a.  
 
4.2.3 RNA quantification, quality assessment and RNA seq 
Same as mentioned in materials and methods section of Chapter 2. Sequencing produced 
millions of short reads which were aligned on the human genome using PASS program 
(9).  
 
4.3 Result:  
Anchorage of muscle cells to the extracellular matrix is crucial for a range of fundamental 
biological processes including migration, survival and differentiation. Three-dimensional 
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(3D) culture has been proposed to provide a more physiological in vitro model of muscle 
growth and differentiation than routine 2D cultures. We have characterized cell-matrix 
interactions in 3D muscle culture and analyzed their consequences on cell differentiation. 
Our goal was to develop a comprehensive understanding of how 3D culture modulates the 
muscle differentiation  using NGS technology. 
4.3.1 Cell Observation in 3D culture 
CHQ5B cells were grown on tissue culture plastic and matrigel surface. In 3D culture, 
after 24 hours of differentiation medium addition myoblasts began to fuse forming 
bundles of myotubes, which progressively aligned generating elastic, elongated structure. 
In 3D culture, after the switch to the differentiation medium, cells fused to form long, 
multinucleated myotubes that were well aligned along the longitudinal axis of the gel 
(figure 4-2). This pattern contrasted with the large branched myotubes and random cell 
orientation usually observed in routine 2D cultures (figure 4-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1: Phase contrast image of myotubes cultured 
and differentiated on 2D plastic surface. Cells were 10 
days differentiated.     
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Figure 4-2: Time course of human primary myoblasts culture inside the micrometric channels 
and schematic representation of the experiment performed for analysing the differentiation 
level of the 3D myoblasts culture. An overall image of a single bundle of myotubes within its 
channel is reported; total length 15 mm.  
 
Myotube formation was assessed by immunostaining for the presence of myosin heavy 
chain, α-actinin and dystrophin on 3D myotubes bundles obtained 5 and 10 days after 
myoblasts injection in the micrometric channels and extracted from the hydrogel 
scaffolds (figure 4-3). 
 
 
 
 
 
 
 
 
 
Figure 4-3: Confocal microscopic images of myosin heavy chain, α-actinin and dystrophin 
staining of CHQ5B cells during the process of differentiation in 3D culture. Images show the 
cross section through the middle of channels of matrigel for 5 and 10 days of differentiation.     
 
4.3.2 Transcriptome analysis of 2-D, 3-D cultivated myotubes and human adult 
skeletal muscle tissue   
We performed an extensive comparison of transcriptomes of 2D, 3D cultured myotubes 
and human adult skeletal muscle to address two things, firstly to find out the 
transcriptional variability that happen due to the change in culture conditions and 
secondly to address the correlation, 2D and 3D cultured myotubes share with the skeletal 
muscle tissue. Both cell culture conditions were compared with each other as well as with 
the adult skeletal muscle tissue. By comparing the transcriptomes we found out 
differentially expressed genes. Differentially regulated genes were identified using edgeR 
 
MHC	 α-ACTININ	 DYSTROPHYN	 MHC	 α-ACTININ	 DYSTROPHIN	
25	µm	
DAY	5	 DAY	10	
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(2) combined with false discovery rate (FDR) method (3). A statistical significance of p < 
0.05 was used for the comparisons.  
We found 1053 genes (731 up, 322 down regulated) differentially expressed in 3D 
myotubes when compared to 2D. 1570 genes (480 up, 1090 down regulated) and 4724 
genes (2481 up, 2243 down regulated) were differentially expressed in skeletal muscle 
tissue when compared to 3D and 2D cultured myotubes respectively (figure 4-4). Our 
results showed that transcriptome of myotubes cultured under 3D conditions show greater 
similarity to adult skeletal muscle tissue transcriptome, when compared to 2D cultured 
cells, as can be seen from the smear plots shown in figure 4-5. The extent of overlap 
between transcriptomes of two culture conditions and the skeletal tissue is shown by the 
venn diagram of figure 4-6. Minimal overlap was found between 2Dvs3D and 
3DvsSkeletal muscle. 248 genes were found in common between genes differentially 
upregulated in 3D and skeletal muscle tissue when compared to 2D cultured cells. 
 
 
 
 
 
 
 
Figure 4-4: Bar plot showing differentially up and down regulated genes in 2D, 3D culture and 
skeletal muscle tissue. The bar plot shows genes differentially up and down regulated. The 
differential expression of genes was found by comparing two samples. (3D vs 2D – 3D culture vs 
2D culture, SK vs 3D – Skeletal muscle vs 3D culture, SK vs 2D – Skeletal muscle vs 2D).     
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                   A                                                     B                                                    C 
Figure 4-5: Scatter plot showing differential gene expression in 2D, 3D cultures and skeletal 
muscle tissue. (A) 2D vs 3D culture (B) 2D vs Skeletal muscle tissue (C) 3D vs Skeletal muscle 
tissue. The plots show that highest numbers of differentially expressed genes are found when 2D 
culture is compared with Skeletal muscle tissue.      
 
 
 
 
 
 
                                                                                                                         
 
 
                                          
Figure 4-6: Venn diagram shows overlap between three sample pairs (2D vs 3D, 3D vs SkM, 
2D vs SkM). Shown in red are the number of genes upregulated and shown in black are the genes 
down regulated. Maximum overlap is found between 3D vs SkM and 2D vs SkM. (2D – 2D 
cultured myotubes, 3D – 3D cultured myotubes, SkM – Skeletal muscle).    
 
2D vs 3D 3D vs SkM 
2D vs SkM 
11↑, 42↓ 
206↑, 224↓ 472↑, 880↓ 
11↑,42↓ 
731↑ in 3D, 
322 ↓ in 3D 
480 ↑ in SkM, 
1090 ↓ in SkM 
2481 ↑ in SkM, 
2243 ↓ in SkM 
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4.3.3 Gene Ontology (GO) and Pathway analysis 
To understand the underlying biological message, the differentially expressed genes were 
subjected to GO and pathway analyses.  DAVID (Database for annotation, visualization 
and integrated discovery), a software which can cluster genes according to their 
functions
8
 was used to analyze all the differentially expressed genes.  
The most significantly enriched biological process terms found by GO analysis for genes 
differentially upregulated in skeletal muscle tissue compared to 3D and 2D cultured 
myotubes, largely remained the same. The biological process terms showing prominent 
enrichment (p value < 0.05) included immune, defence and inflammatory responses and 
response to wounding. Up regulated genes in skeletal tissue compared to 2D culture, also 
showed considerable enrichment of cellular respiration, respiratory ETC (electron 
transport chain) and oxidative reduction. All the enriched biological processes, cellular 
compartment and molecular function terms for genes differentially over expressed in 
skeletal tissue have been listed in supplementary tables (S4-1A, S4-3A).  For genes down 
regulated in skeletal muscle tissue compared to 2D and 3D culture conditions, biological 
process terms of cell adhesion, biological adhesion, extracellular structure organization 
showed substantial enrichment (supplementary table  S4-1B, S4-3B).  
For genes upregulated in 3D culture compared to 2D culture, immune related response 
and apoptosis regulation were the most prominent biological process terms enriched. 
Genes down regulated in 3D culture were enriched for biological processes of cell 
adhesion, biological adhesion and extracellular structure organization (supplementary 
table S4-1A and B). Genes upregulated in 2D cultured myotubes compared to myoblasts 
shows enrichment for biological processes of muscle process development, striated 
muscle contraction and muscle cell differentiation (supplementary table S4-4A and B). 
Upregulated genes found common between 3D and skeletal muscle as compared to 2D 
culture showed enrichment for biological processes of immune, defense, inflammatory 
responses and response to wounding.        
Pathway analysis using KEGG database showed a common enrichment for metabolic 
processes for genes upregulated in skeletal muscle tissue as compared to both 2D and 3D 
cultured cells. A lot of genes were found participating in immune related pathways (table 
4-1 A and B). 
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                                  A                                                                        B 
Table 4-1: (A) KEGG Pathways for gene upregulated in skeletal muscle tissue as compared to 
3D cultured myotubes. The number of genes involved in each pathway is shown in the 
corresponding column. (B) KEGG Pathways for gene upregulated in skeletal muscle tissue as 
compared to 2D cultured myotubes. . The number of genes involved in each pathway is shown in 
the corresponding column.    
4.3.4 Transcriptome of 3-D compared with 2-D cultured myotubes      
Some important differences were noted on comparison of the transcriptome of both 
culture conditions. With a FDR of 0.05, we found 731 genes were up regulated and 322 
genes were down regulated in CHQ5B myotubes differentiated in 3D culture system. 
83% of the upregulated genes and 63 % of down regulated genes were protein coding 
(Figure 4-7A). Genes found most significantly up regulated in 3D culture conditions were 
known myokines, a variety of cytokines and other immunologically relevant molecules. 
5% of upregulated genes showed a fold change of > 5x.   
The most prominent group of genes showing upregulation were contraction induced 
myokines, interleukins, cytokines and other immune related molecules under 3D culture 
conditions. Genes showing strongest upregulation were CFS3, IL8, CHI3L1, CXCL1 and 
CXCL6 (table 4-3). 8% of significantly over expressed genes were of those producing 
immune response molecules.  
Genes of IL8 and IL24 showed highest fold increase of 8x. Other interleukin genes like 
IL1A, IL1B, IL24, IL32, IL33, IL6, IL8 and IL11 were also remarkably upregulated. 
Chemokines like (C-X-C motif) CXCL1, CXCL12, CXCL2, CXCL3, CXCL5, CXCL6 
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and (C-C motif) CCL2, CCL20 were also noticeably upregulated. Many other mRNAs for 
immunologically relevant molecules were also differentially upregulated.  
Terminal differentiation of muscle cells are governed by a network of four MRFs: 
myogenic factor 5 (MYF5), muscle specific regulatory factor 4 (MRF4 also known as 
MYF6), myogenic differentiation protein (MYOD1) and myogenin (MYOG). MRFs are 
transcriptional factors that activate many downstream genes to initiate muscle cell 
differentiation. MYF5 and MYOD1 act as determination genes, whereas myogenin is 
essential for the terminal differentiation of committed myoblasts (10). Three of the four 
MEF2 (myogenic enhancer factor) proteins (MEF2A, MEF2C and MEF2D) are 
expressed in skeletal muscle
12
. MEF2 directly interacts with MYOD (11). SMAD7 by 
interacting with MYOD also, regulates differentiation of skeletal muscle cells (13). Under 
3D culture condition, MYF6, MYOD1, MYOG, MEF2A, MEF2D and SMAD7 were 
found upregulated (Figure 4-7B).      
 
 
 
   
 
 
 
 
                    A                                                                                   B                                        
Figure 4-7: (A) Differential gene expression profile of 3D cultured cells when compared to 2D 
culture. Doughnut curves show the distribution of protein coding (PC) and non-protein coding 
(NPC) gene for differentially up and down regulated genes. (B) Muscle specific gene expression 
2D and 3D culture conditions. From the bar curve it is seen that these genes are over expressed 
in 3D culture as compared to 2D culture.    
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Adhesion proteins like Integrin, ADAM12, CD9, CD81, M-cadherin and VCAM-1 play 
important role in myoblast fusion and myotube formation
14
. Integrins are transmembrane 
receptors which have the dual function of attachment of cells to the ECM and signal 
transduction from ECM to cells. Alpha and beta subunit genes of integrin were up 
regulated. ITGA8, ITGB3, ADAM12 and CD81 showed upregulation whereas other 
genes did not show any change. Collagen and laminin which play important role in 
formation of muscle specific extracellular matrix
15
 were also found to be upregulated in 
3D culture. Myoglobin showed 3x fold increase. Matrix metallopeptidases (MMP) have 
their essential role documented in skeletal muscle healing and extracellular matrix 
reorganization (16) were also found upregulated in 3D culture. Members of fibulin gene 
family, which are secreted glycoproteins that become incorporated into a fibrillar 
extracellular matrix when expressed by cultured cells, were turned up (24). Table 4-2 
enlists all these genes. 
 
       
  
 
 
 
 
Table 4-2: Genes upregulated in 3D cultured myotubes as compared to 2D cultured myotubes. 
Corresponding columns give the description of each gene and their log2 FC.   
 
 
 
 
 
 
  
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
89 
 
Table 4-3: Genes showing ≥ 4 log 2 fold increase under 3D culture conditions as compared to 
2D culture condition. Table gives the gene name with their description, log2FC and 
corresponding P-Value. 
 
4.4 Discussion 
With this experiment of my PhD work, I have studied the modulation of the transcriptome 
of human skeletal muscle cells under 2D and 3D culture conditions. The transcriptome 
analysis shows that the  transcriptome of 3D cultured cells shares a greater degree of 
similarity with that of adult skeletal muscle tissue. By comparing the transcriptomes of 
the two different culture conditions and adult skeletal muscle tissue we have identified all 
of the genes that were differentially up- and downregulated. From this  comparison we 
found many immune related genes were prominently over-expressed under 3D culture 
conditions. There is a growing set of evidence supporting the role of immune specific 
molecules in muscle growth and regeneration (26). The elevated immunogenic response 
of 3D cultured myotubes was of significant interest to us.          
It is known that the process of myofiber formation requires precise regulation of myoblast 
fusion (18, 19). Myoblast fusion is a highly complicated event during which myoblasts 
fuse with each other to form myotubes which in turn enlarge the myofiber. Our study 
demonstrates the impact of a 3D culture environment on the differentiation of human 
skeletal myoblast cells (CHQ5B cells). We addressed the influence of the 3D culture 
system by comparing the entire transcriptome of myoblast cells differentiated under 2D 
and 3D culture conditions. The whole transcriptomes were sequenced using NGS 
technology. Muscle cell differentiation is a concerted process which involves a number of 
events like myoblast proliferation, migration, elongation and fusion. Cells in tissue are in 
a 3D micro-environment having characteristic biophysical and biochemical signals. The 
normal function of most cells and tissues depend on interaction with neighbouring cells 
and the extracellular matrix. It is difficult for 2D monolayer cultures to mimic the 
physiological situation in vivo. Hence, recapitulating the function of ECM and 3D cell 
interactions is an important aspect of investigating molecular mechanisms of 
differentiation.       
On comparing 2D and 3D cultures we found an upregulation of muscle differentiation 
markers like MYOD1, MYOG, MRF6 (Figure 4-7B) under 3D culture condition, which 
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is consistent with a previous report (17). Baeza-Raja and Munoz-Canoves demonstrated 
the positive role of NFĸB during skeletal muscle differentiation and its activation which is 
required for IL6 production which is a promyogenic molecule (20). In C2C12 myotubes 
the inflammatory cytokine IL-1 isoforms, IL-1α and IL-1β have been shown to stimulate 
nuclear factor ĸB (NF ĸB) signalling (22). We found two NFĸB members NFĸB2, RELB 
and IL6, IL-1α, IL-1β all considerably upregulated under 3D culture conditions.  Armand 
et al. have shown the involvement of the Calcineurin/NFAT signalling pathway in 
myogenin expression during skeletal muscle development. They showed the role of two 
NFAT family members NFATc2 and NFATc3 and their synergistic cooperation with 
MyoD during skeletal muscle development (21). We found NFATc2 and NFATc4 were 
over expressed in 3D cultured myotubes along with MRF members. In primary mouse 
muscle cells a large number of chemokines were found to be expressed during cell-cell 
fusion and their role in cell migration and positioning myocytes in correct spatial pattern 
necessary for cell fusion has been speculated by Griffin  et. al (23). Although the in depth 
knowledge of the role pf chemokines  and their mechanism of action during muscle 
development is lacking, high level of expression of chemokine ligands during muscle 
development is  a strong indication of that chemokines play some important role in 
myogenesis. In accordance with the findings of Griffin  et al, we also found several 
chemokine ligands were overexpressed in 3D culture conditions (supplementary 
information).        
The most interesting finding of our work was the exclusive and prominent ove -
expression of genes for myokines, interleukins and several immunogenic response 
molecules in 3D culture. Within the last decade skeletal muscle has been identified as a 
secretory organ (6)
 
and the cytokines secreted by muscle cells are collectively termed as 
myokines (4). The role of interleukins and myokines are well documented in exercising 
muscles. Myokines also have their roles in regulation of cellular expression, 
differentiation, tissue regeneration and repair, as well as immunomodulation and 
embryogenesis. Positive effects of myokines are associated with their transient production 
and short term action (5). Pedersen and co-workers have recently shown the role played 
by contractile activity in regulating the expression of cytokines by skeletal muscle (7). In 
order to understand our findings better we compared the transcriptomes of both 2D and 
3D cultures with the adult human skeletal muscle tissue transcriptome. We found that 
myotubes cultured under 3D conditions shared greater similarity to the transcriptome of 
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adult skeletal muscle tissue, as compared to 2D cultured cells (Figure 4-5). GO analysis 
of genes differentially over-expressed in skeletal muscle tissue when compared to both 
2D and 3D culture showed a common enrichment for the biological processes of immune 
response, inflammatory response, defence response and response to wounding. Pathway 
analysis showed, metabolic pathways dominated along with many immune related 
pathways (Table 4-1). Our results of full transcriptome analyses of muscle cells cultured 
under 2D and 3D culture systems and skeletal muscle tissue, show that development of 
immunogenic capacity is a prominent process and an important aspect of muscle 
development, as has been mentioned by Pillon et al that skeletal muscle undergoes 
continuous repair as a result of contractile activity which requires the participation of 
myokines and anti-inflammatory input (25).  
GO analysis showed that genes responsible for muscle oxidative metabolism like cellular 
respiration, electron transport chain, generation of precursor metabolites and energy, 
oxidative reduction were under-expressed under 2D culture conditions. Whereas,  
immune specific genes were over-expressed and immune related processes were enriched 
for genes differentially over-expressed in 3D culture and skeletal muscle.     
In summary, we have thoroughly studied the transcriptomic behaviour of CHQ5B cells’ 
differentiation under 2D and 3D culture conditions. We compared the transcriptomes of 
both culture conditions with adult human skeletal muscle tissue and found that cells 
differentiated under 3D conditions share a higher degree of similarity with the skeletal 
muscle tissue transcriptome. Cells differentiated in 2D culture showed enrichment for 
muscle specific processes like muscle development and contraction. Whereas, cells 
differentiated under 3D culture conditions showed elevated immunogenic response, as 
many cytokine, myokine, and interleukin genes were significantly over-expressed, which 
indicates that the immunogenic capacity that is innate to skeletal muscle for both 
development and regeneration is more pronounced in 3D culture conditions that 2D 
conditions. Skeletal muscle tissue transcriptome also showed immunogenic response as 
the most prominent biological process. Our study shows how 3D cultured myotubes 
mimic actual skeletal tissue better than 3D culture systems. Our results demonstrate that 
skeletal muscle cell differentiation is enhanced in a 3D culture system compared to 2D 
culture system.          
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Chapter 5 
 
Stretching stress response of 
differentiating human myotubes  
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This work was also performed in collaboration with Professor Nicola Elvassore of 
“Dipartimento 
Di Ingegneria Industriale, Universita Degli Studi di Padova”. The work was carried out 
with 
Lia Prevedello, a PhD student working with Prof. Elvassore. We undertook this 
collaboration mainly as our interest to elucidate skeletal muscle response to mechanical 
stretch. We cultured the cells on PDMS membrane devices for stretching and with the 
next generation sequencing facility in our lab we performed the RNA seq of muscle cells 
after stretching. The RNA seq result analysis was also performed by us. PDMS 
membrane device preparation and mechanical stretching were performed in the 
Dipartimento Di Ingegneria Industriale. CHQ5B cells were used for this experiment. 
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5.1 Introduction: 
Skeletal muscle is highly adaptable and responds to changes in loading through exercise 
or resistance training through a number of mechanisms resulting in increased muscle 
mass and changes in contractile phenotype. The remarkable ability to adjust to changes in 
physiological requirements involves a concerted control of transcription regulation. 
Stretch stimulates skeletal muscle growth (5). Our study was aimed to investigate the 
molecular events that happen as a part of adaptation in skeletal muscle cells to mechanical 
stretch.  We tried to decipher the process of adaptation by studying the changes in the 
transcriptome using NGS technology. We tried to capture both the immediate response 
and delayed response to mechanical stretch by investigating the transcriptome at two time 
points: 3h post stretch and 40h post stretch. We compared the transcriptome of stretched 
cells with unstretched controls. It is known that mRNA decay rates in human vary from 
being as short as 2h to more than 50h (6). For example dystrophin transcript has a half-
life of 15 ± 2.5h in human muscle (7). Our reason behind doing RNA seq analysis at 3h 
and 40h post stretch was to capture short lived mRNAs which might be turned up as a 
response to stretch and also we to assess the long lasting effect of stretch on skeletal 
muscle cells. To have more confidence in our results we performed two replicas for each 
time point.  
 
Experimental plan: We cultured human primary myoblast cells (CHQ5B) on PDMS 
membrane devices (described in materials and methods). Differentiation was induced by 
serum withdrawal. 24 hours after initiation of differentiation, mechanical stretching was 
performed for 30 minutes continuously (stretching conditions described in materials and 
methods). Post stretch, cells were left under differentiating conditions for 3h and 40h. We 
did mRNA extractions at these time points. So, our transcriptomic analyses were carried 
out at 28h and 68h of myotube formation. We had controls i.e. non stretched cells 
differentiated for 28h and 68h. RNA seq was performed for stretched and control cells.  
Our experimental design is depicted in the following figure: 
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                                   Schematic representation of the experiment 
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5.2 Materials and Methods: 
5.2.1 Cell culture and stretch 
CHQ5B cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 
20% fetal bovine serum and 100µg/ml gentamycin in a humidified incubator containing 
6% CO2 at 37ºC. For stretching cells were then cultured for an additional 24 hours in 2% 
horse serum.   
PDMS membrane for stretching:  
In order to carry out stretch, a special elastic surface made out of PDMS 
(Polydimethylsiloxane), Sylgard 184 (Dow corning) in a 1:10 ratio of curing agent (cross 
linking agent) and base (prepolymer) was fabricated for culturing the cells. The 
membrane was very soft with high elasticity. The surface area of the membrane for cell 
culture was 3*3cm
2
. Myotubes when cultured on plastic cell culture dishes acquire a 
branched and spread out structure, but is not ideal to carry out a uniaxial stretch since the 
cells are not aligned unidirectional. To obviate this, channels of 100µm diameter were 
imprinted on the surface of the PDMS membrane. For cell culture, the PDMS membranes 
were treated with laminin. Laminin treatment procedure was as follows: 
For one cell culture, the membrane was treated with 4.5µg (0.5µg/cm
2
) of laminin 
solution made in PBS. Each membrane was treated with 3ml of laminin solution and then 
allowed to dry under laminar hood for overnight. The following day, after the PBS was 
evaporated the membrane was washed once with PBS to remove any leftover salt crystals.  
Cells were grown on laminin treated PDMS membranes for the purpose of stretching.  
5 X 10
5
 CHQ5B myoblast cells were cultured on one PDMS membrane, followed by their 
differentiation (figure 4-1B).  
Stretching conditions: 
Cultured cells were subjected to uniaxial continuous mechanical stretch for 30 minutes in 
strain providing instrument (ElectroForce Planar Biaxial 4 Motor TestBench, BOSE). 
Cells were 10% stretched at 0.2 Hz. Stretching was performed under incubation at 37ºC 
with 5% CO2.  
(The stretching device with CO2 incubator mounted is shown in figure 5-1A). 
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Figure 5-1: (A) ElectroForce Planar Biaxial 4 Motor TestBench instrument for stretching with 
incubator mounted on it. Various parts are labeled. (B) PDMS membrane with cells fitted 
between the clamps of the stretching instrument. Arrow shows the direction in which stretching 
was carried out.  
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Figure 5-2: (A) PDMS membrane device used for cell culture and stretching. (B) Cartoon of 
assembly of the device. Microscopic image of CHQ5B cells growing on PDMS membrane with 
channels (C) Image taken at 20X magnification. Multinucleated myotubes can be seen. (D) Image 
taken at 10X magnification. Channels and unidirectionally aligned cells can be seen.  
 
5.2.3 RNA extraction and transcriptome sequencing 
We wanted to study the immediate and late response of the CHQ5B cells to mechanical 
stretch by transcriptomic analysis. So, mRNA was extracted using Amersham kit. mRNA 
were extracted at 3h and 40h post stretch. mRNA was also extracted from corresponding 
controls. After quantification and quality assessment, RNA samples were proceded with 
RNA seq protocol (RNA seq procedure mentioned in details in materials and methods 
section of chapter I). 
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5.2.4 Immunofluorescence 
Primary human muscle cells (CHQ5B) were grown on PDMS membrane and 
differentiated for 3 days. Cells were washed 3 times with PBS then fixed with ice cold 
methanol for 15 minutes.  Then the membrane were treated with 0.1M glycine for 5 
minutes and then 0.05% Tween-20 and 5% BSA (bovine serum albumin) for 1 hour to 
permeabilize the cells and to block any nonspecific signals. All the washings and 
antibody dilutions were performed in PBS with 0.1% BSA and 0.05% Tween-20. The 
samples were incubated with following primary antibody for overnight: Myosin 
monoclonal antibody (MF20)- (1:20 dilution). The secondary antibody was anti-mouse 
fluorescein isothiocyanate (FITC) conjugated (Sigma, F 4018). The nuclei were stained 
with 4',6-diamidino-2-phenylindole (DAPI) (0.33 µg/ml). Finally after several washes, 
the coverslip was mounted on the membrane using glycerol-PBS (50:50) as the mounting 
medium and examined under a fluorescence microscope (Leica) at both 10X and 20X 
magnifications.     
  
5.3 Results 
5.3.1 Differential gene expression analysis 
Analysis of differentially expressed genes after 3h of stretch in comparison with the 
control identified 142 genes differentially expressed (88 up (> 1.4X), 54 down (< -1.4X)). 
We observed 10 times more genes were affected after 40 hours of stretching when 
compared to control. Total 1447 genes showed differential expression, with more genes 
being down regulated (969) and 478 genes were upregulated (figure 5-3D). When 40h 
post stretch was compared with 3h post stretch, highest numbers of genes (1980 genes) 
were found altered (1093 up, 887 down).  The scatter plots of figure 5-3A,B,C show the 
effect of stretching on transcriptome at 3h and 40h post stretching.  
Number of genes with differential expression between 27h and 65h of differentiation of 
cells that were not stretched was far less than cells that were stretched. (figure 5-3E). 
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Figure 5-3: Differential gene expression analysis shown through scatter and bar plots. (A) 
Differential gene expression between 3h post stretch and control. (B) Differential gene expression 
between 40h post stretch and control. (C) Differential gene expression between 3ha nd 40h post 
stretch. Red dots represent differentially expressed gene. (D) Bar plot shows differentially up and 
down regulated genes between two samples (3h PS vs control – 3h post stretch vs control, 40h PS 
vs control – 40h post stretch vs control, 3hPS vs 40h PS – 3h post stretch vs 40h post stretch). (E) 
Plot shows genes differentially expressed between 3h and 40h post stretch control samples and 3h 
and 40h post stretch samples. (3h PS cont vs 40h PS cont – 3h post stretch control vs 40h post 
stretch control, 3hPS vs 40hPS – 3h post stretch vs 40h post stretch)  
5.3.2 GO and pathway analysis 
To evaluate the biological functions of the observed transcriptomic changes, we searched 
for enriched GO terms and also performed pathway analysis using KEGG database. For 
genes upregulated after 3h of stretch in comparison with control, GO terms related to 
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immune response, response to wounding, cell proliferation, taxis and chemotaxis were 
enriched. Pathway analysis was done for all the genes differentially expressed and it 
showed enrichment of cytokine-cytokine receptor interaction, TNF signaling pathway and 
chemokine signaling pathway (figure 5-4A and supplementary table – S5-2 A & B). 
Genes up regulated after 40 hours of stretching vs control showed enrichment for 
biological process terms of L-serine metabolic process, response to nutrient levels, 
cellular response to insulin stimulus. However genes down regulated after 40 hours were 
enriched for biological processes of response to wounding, inflammatory response, 
locomotory behavior, defense response (supplementary table – S5-3 A & B). Pathway 
analysis of genes differentially affected after 40 hours showed a clear enrichment of 
metabolic pathways (figure 5-4B).  
Differentially expressed genes 40h after stretch in comparison with 3h after stretch, 
showed enrichment of muscle specific biological process terms of muscle contraction, 
muscle system process, muscle organ development (supplementary table – S5-4 A & B). 
Pathway analyses showed most of the effected genes were involved in metabolic 
pathways, followed by pathways in cancer, PI3k-Akt pathway (fig 5-4 C). 
GO and pathway analysis shows that initially after stretching immunogenic response if 
triggered which goes down with the passage of time. The long term effect of stretching is 
mostly reflected through the change in metabolic behavior of the cells.    
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Figure 5-4: KEGG pathway analysis (A) Genes differentially affected after 3h of stretch 
compared to control. (B) Genes differentially affected after 40h of stretch compared to control. 
(C) Genes differentially affected after 40h of stretch compared to 3h post stretch. Percentage of 
genes belonging to each pathway is shown.  
 
5.3.3 Myokine genes over expression as an immediate response to stretch 
RNA seq analysis performed after 3 hours of stretch to capture the immediate response to 
stretching at transcriptome level showed many cytokine ligands and myokine genes 
strongly upregulated: CXCL3(5x fold up),  CXCL1, CXCL6, IL1B and IL8 (>4x fold 
up),  IL11, IL24, IL6, CXCL5 and CCL2 genes were >2x fold increased. MYH15 and 
MYH13 genes were >2x fold enriched. But these genes were found down regulated after 
40h of stretch (table 5-1). However after 40h of stretch other set of myokine and 
interleukin genes were turned up which were not found effected after 3h of stretch. These 
genes with their log2 fold change have been listed in table 5-1. 
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5.3.4 3h post stretch response analysis 
Transcriptome analysis showed CXL3, CSF3 and EDNRB genes most prominently 
upregulated. They were > 5x up regulated. 88 genes were differentially upregulated after 
3h of stretch. Genes upregulated >2x fold have been shown in supplementary table S5-5. 
To figure out, if this effect of gene upregulation is long lasting or just transient, we 
compared the genes upregulated after 3h of stretch with genes under expressed after 40 
hours of stretch. The noticeable observation we made was, 72 genes out of 88 genes 
significantly up regulated after 3h of stretch were considerably down regulated after 40h 
of stretching. The list of these genes is shown in table 5-2.  
Another interesting observation was that the myokine genes which were immediately 
turned up following stretch were also found upregulated after almost 3 days of 
differentiation of the cells which were not stretched. Meaning that, stretching caused 
upregulation of myokine genes after 3h of stretch (i.e. 27 hours of differentiation) which 
are turned up after around 65 hours of normal process of differentiation without any 
 
Table 5-1: Myokine, interleukin and 
chemokine genes affected due to 
stretch. Shown are genes that were 
over expressed after 3h of stretch but 
decreased significantly after 40h of 
stretch. Also shown are those genes 
which were upregulated after 40h of 
stretch but not differentially affected 
after 3h. (colums left blank show no 
differential expression)   
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stretching. We observed this for CSF and EDNRB3 genes also which were prominently 
over expressed 3h after stretch. This observation is illustrated in figure 5-5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-5: Plot showing pattern of gene expression between control for 3h post stretch (i.e 27 
hours of differentiation), 3h post stretch, control for 40 h stretch (i.e. 67 hours of 
differentiation) and 40 h post stretch samples. It is clear that these genes are over expressed 3h 
after the stretch but goes down after 40h of stretch (A) CXCL2, CSF3, EDNRB genes are shown. 
CXCL2 and CSF3 are highest expressed 3h post stretch (B) CXCL3, CXCL1 and IL1B are 
optimally expressed after 40h of stretch (C) LINC00473 (linc RNA), IL8 and CXCL6 also show 
similar pattern (3h con – 3h post stretch control, 40h con – 40h post stretch control. 
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Table 5-2: Genes upregulated after 3h of stretch but significantly down regulated after 40h of 
stretch. 
 
We wanted to find, if stretching enhances the process of muscle differentiation. In order 
to find that we compared genes upregulated after 3 hours of stretching with those genes 
which were over expressed after almost 3days of differentiation. We found 50 common 
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genes. The list can be found from supplementary table S5-1. The log2 fold change for all 
these genes were very similar, except for few genes like FGF7, MYH15, MMP3, BMP6, 
RCAN1, CXCL5, CXCL6, HSD11B1 and PADI2 which were more upregulated after 3 
days of differentiation as compared to 3h post stretch. 
5.3.5 40h post stretch response analysis 
We compared the transcriptome of cells after 40 hours of stretching with the control 
transcriptome. 478 genes were upregulated. Genes more than 2x fold increased are shown 
in supplementary table S4-6. GRIN2A, ANO1 and HRK were the most prominently 
upregulated genes after 40h of stretch which showed >4x fold increase. Muscle specific 
genes showed very little upregulation. Muscle specific genes with their descriptions and 
fold change in bracket are mentioned below:  
MYBPC1 – Myosin binding protein C, slow type (1.29), MYL1 – Myosin, light chain 1, 
alkali, skeletal, fast (1.41), MYLPF – Myosin light chain, phosphorylatable, fast skeletal 
muscle (0.71), MYO1D -  Myosin ID (0.80), MYO1G – Myosin IG (1.61), MYOM2 – 
Myomesin (M protein) 2 (0.81), MYOZ2 – myozenin (0.90). Aldehyde dehydrogenase 
genes (ALDH1L2, ALDH3A1, ALDH5A1) were up regulated. Integrin genes (ITGA6, 7, 
ITGB6, ITBG1BP2, 3) were over expressed compared to 3h post stretched cells, however 
these genes were not upregulated after 65 hours of normal differentiation. Genes for 
collagen (COL15A1, COL4A1, COL6A6) and Insulin like growth factor (IGF2) were 
turned up compared to control. Voltage gated sodium channel gene (SCN7A) was 2.2x 
fold over expressed after 40h of stretch. Apolipoprotein genes (APOL5, 6) were >1.5x 
and APOM gene was 3.3x upregulated. Many myokine, cytokine genes were prominently 
down regulated as has been mentioned already.  
C2CD4A, CSF3, SDIM1 and IL8 were most prominently down regulated genes. Many 
other interleukin and myokine genes were also found down regulated as has been 
previously mentioned.   
5.3.6 Stretching propels the process of muscle cell differentiation at transcriptomic 
level 
Aside from understanding the immediate and long term response of differentiating muscle 
cells to mechanical stretch, we also tried to find if stretch enhances the process of 
differentiation. To answer that, we compared the transcriptome of muscle cells 3h after 
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stretch with that of 40h after stretch. The myokine gene expression alteration has already 
been mentioned in previous section. As an obvious expectation we found after 40 hours 
of stretch the differentiating cells which further advances into differentiation, turns up 
many muscle specific genes. We found 24 muscle specific genes upregulated after 40h of 
stretch, whereas only 14 muscle specific genes were turned up in the control cells for 40h 
in comparison with 3h control cells. (data shown in table 5-3). Stretching caused 
upregulation of muscle differentiation marker myogenin (MYOG), which was not found 
upregulated in non-stretched cells. 
Immunofluorescence showed upregulation of myosin light chain expression after 40h of 
stretch (figure 5-6). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5-3: Muscle specific genes found upregulated after 40h of stretch vs 3h stretched cells 
and in control for 40h stretch vs control for 3h stretched samples.   
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Figure 5-6: Immunofluorescence analysis of  myosin light chain on (A) control cells for 40h 
post stretch-10X image (B) 40h post stretch- 10X image (C) Control cells for 40h post stretch – 
20X (D) 40h post stretch – 20X image. 
 
5.4 Discussion 
The major aim of our study was to investigate the adaptation at transcriptomics level of 
growing human myotubes when stretched. We performed the study at two time points of 
3h and 40h post stretch. We found far more genes affected after 40h of stretching than 
after 3hours. After 3hours mainly genes for myokines, chemokine liagnds and interleukin 
were upregulated. 79% of genes upregulated after 3h of stretch were considerably down 
regulated after 40h of stretch, indicating that immediate response to stretch was transient. 
After 40 h of stretch however we found IL16, 17B, 20RA, 2RG, 32, 34 and 1R1 genes 
upregulated which were not upregulated as an immediate response to stretch. IL1B and 
IL6 genes which were upregulated after 3h of stretch declined after 40h.  IL1B is known 
to stimulate IL6 production in skeletal muscle cells (8) Despite their role in muscle 
development, their down regulation after 40h of stretch might indicate that the usual 
process of muscle development gets perturbed due to stretch. CSF3 gene was strongly 
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upregulated shortly after muscle stretch. CSF3 gene encodes for cytokine. Colony 
stimulating factor is known to enhance muscle proliferation and strength following 
skeletal muscle injury (11). CXCL1, 2, 3 and 6 genes were also upregulated as a quick 
response to stretch.  
We observed that many more myosin family genes were upregulated after 40 hours of 
stretch compared to its unstretched control (table 5-3). Brunello E et al, has shown that 
skeletal muscle resists stretch by binding of myosin motor domain to actin(1). They have 
shown that a stretch, strains attached myosin motor domain which promotes the 
attachment of second motor domain, which in turn allows skeletal muscle to resist 
external stretch without increasing the force per motor. This stands as a possible 
explanation for our observation of more myosin family genes expressed after stretching as 
that assists the cell to withstand the stress caused due to stretch. Although commenting 
about it to be surely happening without the knowledge of what happens at the proteomic 
level is difficult, but with Schwanhäusser et al. study performed on mammalian tissue 
culture cell, showing that a good correlation between mRNA and protein levels exists, 
and that mRNA levels are the most important factor when predicting the protein levels 
(10) does provide more confidence to our interpretations. Genes for membrane spanning 
protein integrins and extracellular matrix collagen proteins were upregulated after 40h of 
stretch compared to the control. Integrins are present at Z-line and have the capacity to 
bind extracellular and intracellular molecules, which provides a link between basement 
membrane and cytoskeleton (2). They play a role in force transmission to the contractile 
apparatus of muscle (3). We found an upregulation of apolipoprotein genes after 40h of 
stretch. Apolipoproteins’ have been shown to be derived from C2C12 myocytes (4), 
however we do not know the correlation between stretching and upregulation of 
apolipoprotein genes, but their over expression does indicate of some role being played 
by them as a response to stretch.  
With pathway analysis we found that metabolic pathways were most prominently affected 
pathways as a long term response to stress. However after 3h of stretch cytokine-cytokine 
receptor pathway was the most prominent pathway activated. We also observed PI3k-Akt 
and MAPK signaling pathway enrichment after 40h of stretch. PI3K-Akt pathway 
activation is known to stimulate muscle differentiation and has a role in muscle 
hypertrophy (9). MAPK signaling pathway is stimulated upon exercise in human skeletal 
muscles (12).   
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In this chapter I have elucidated the changes that happen at transcriptomic level, of 
differentiating myotubes shortly and 40h after stretching. Shortly after stretching limited 
number of genes were found perturbed and also that effect was transient as after 40h of 
stretch the gene expression land scape changed. Immunogenic response was an immediate 
response to stretch as was found by gene ontology, pathway analysis and also by the 
upregulation of chemokine ligand, myokine genes. We have also shown that some genes 
which were turned up as a quick response to stretch (3h post stretch) were upregulated 
after 68h of normal differentiation. This indicates that stretch stress hastens some 
molecular aspects of muscle differentiation. The evidences we have presented here 
suggests, that stretch is immediately perceived as an injury by differentiating muscle cells 
and so its innate immune response is triggered. But at the same time, muscle growth 
process is enhanced. Over a period of time the immune response goes down but muscle 
structural protein genes are upregulated. Stretching affects cells’ metabolism over the 
course of time. We have been able to pin point those genes which come out as an 
instantaneous or long standing response to stretch.      
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Summary and Conclusions 
 
My PhD project was thoroughly focused on human skeletal muscle transcriptome. During 
the three years of my PhD I have focused on understanding various aspects of muscle 
development molecular level. First step towards that was having a thorough and 
exhaustive idea of muscle transcriptome. Transcriptomic analysis included miRNA 
profiling also. I have studied muscle development from the stage of myoblast where cells 
are in their proliferative stage, and then they differentiate into myotubes when the 
proliferation stops and cells fuse to become multinucleated specific muscle cells. 
Although there is a lot of research already conducted on the various transcritomic 
modulations that occur during the transition from myoblasts to myotubes, but not that 
everything has been unraveled yet. Next generation sequencing is a more mature and 
powerful technique for studying transcriptomics. NGS have been extensively for my PhD 
project. Using NGS we have obtained the complete picture of the transcriptome as it 
occurs in myoblasts and myotubes. Differential gene expression analysis was performed 
using edgeR software. That gave the whole bunch of genes which change from one 
developmental stage to another. By performing GO analysis, the functional aspects of 
genes differentially expressed were studied. But the skeletal muscle tissue is the 
functional form in human body. So to understand the difference that occurs from the cell 
to the tissue had to be understood. Hence adult skeletal muscle tissue transcriptome were 
sequenced and compared with myotubes followed by GO analysis. At this level the major 
finding was, upon myotube formation, muscle specific genes and muscle structural genes 
get strongly upregulated whereas cell cycle specific genes take a back seat, as after 
myotubes do not have the proliferative capacity. The transcriptome of skeletal muscle 
how ever showed upregulation of many interleukins, cytokines and histocompatibility 
complex genes which were not up regulated at the myotube stage. Skeletal muscle is 
known to have its own immunogenic capacity. However at this stage of my research work 
it was difficult to know how and when exactly the muscle tissue acquires the 
immunogenic capacity, because at the differentiated stage no immune specific genes were 
noticeable expressed.  
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More than thousands of genes were differentially expressed between myoblasts and 
myotubes. It is very unlikely that all of them are under miRNA regulation. It was of 
substantial importance to find out the genes which are directly under the control of 
miRNA regulation. Our approach towards finding out these genes was by carrying out 
Ago2-RNA immunoprecipitation. Argonaute 2 is a component of RISC complex, using 
which miRNA exerts its regulatory control on mRNA. By Ago-RIP, RNA bound to Ago2 
in myoblasts and myotubes were immunoprecipiated and the RNA were then sequences 
using NGS. Immunoprecipitation ameliorates genes bound to Ago2. I compared this pool 
of immunoprecipitated genes with total genes expressed in myoblasts and myotubes. This 
comparison showed many genes enriched with Ago2. Since argonaute 2 has also been 
recently shown to have its role in stabilizing mRNA, it was not possible to accept that, 
enriched pool of RNA were under down regulatory action of miRNA. To fish out the 
most likely gene candidates associated with Ago2 and under miRNA down regulatory 
control, the enriched genes were compared with genes differentially down regulated in 
myoblasts and myotubes. This gave very interesting results. First of all out of the 1000 
genes enriched, only 90 genes corroborated with genes which are turned down at either 
stage of muscle development, which is a very small percentage suggesting that ago2 
associated miRNA down regulates a limited population of genes.  Secondly I found, 
Genes enriched in Ago2 pull down in myoblasts were many skeletal muscle structural 
genes. That is a reliable finding as myoblasts do not express muscle structural genes 
prominently. In myotubes Ago2 enriched, transcription factor genes like Pax7, HoxA11, 
HoxA9 which are known to be down regulated upon muscle differentiation. There are 
many other genes associated with Ago2 which have not been elucidated in muscle 
biology. There is a need of further experiments to find the accurate interaction of miRNA 
with these mRNAs.       
With the miRnome sequencing aside from obtaining the entire population of miRNA and 
their differential expression in myoblasts, myotube and skeletal muscle tissue, I found 
couple of miRNA which were significantly turned up in myotubes as compared to 
myoblasts. In literature very little information exists about these miRNA’s role in muscle 
development. So, analyzing their functional role was of importance. I found miR-139, 
miR-532, miR-660 and miR-92a very interesting due to the limited knowledge available 
about them and the fact that they were differentially upregulated in myotubes. I used 
miR-206 as a positive control because of its well documented role in muscle biology. A 
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scramble sequence was used as negative control. A large scale experiment was designed 
to perform their functional analysis. Myoblast cells were transfected with each of these 
miRNA mimics. The transfection was carried out for 12h and 24h. The time points were 
to observe if the effect of miRNA intensifies with the passage of time or it changes. RNA 
seq of transfected cells at 12h and 24h was carried out. This simple yet exhaustive 
approach, gave bunch of interesting results again. The first observation was, very few 
genes altered after 12h as compared to 24h after each miRNA transfection, indicating the 
effect of miRNA intensifies with time. Another consistent observation was, more genes 
were upregulated and less genes were down regulated at both the time points and with 
each miRNA. With positive control miR-206, muscle structural genes were upregulated 
after 12h and 24h. This is a very strong evidence to suggest that miRNA has a role in 
stabilizing mRNA. We do not say all the genes found affected are being directly acted 
upon by miRNA, but at large these miRNA were found to cause gene upregulation than 
down regulation. Pathway analysis showed all of these miRNA perturbed metabolic 
pathways. Genes upregulated after each miRNA over expression showed involvement in 
transcription and transcriptional regulation. Distinct pool of genes was affected by each 
miRNA. Comparison of genes down regulated after 24h of miRNA over expression with 
Ago2 enriched mRNA in myoblasts, showed that genes involved in muscle development 
like transcription factors and structural genes were down regulated by these 5 miRNA in 
myoblasts. I did not find any did not find any enhancement of differentiation after the 
over expression of these 5 miRNA. Rather the results show that these miRNA although 
expressed at a lower level in myoblasts have their distinct function in myoblast as they 
keep genes involved in muscle differentiation and development, turned down. It could 
also be hypothesized that the pool of genes down regulated by these miRNA in myotube 
would be different from the genes kept down in myoblasts. Meaning that same miRNA at 
different level of cellular development plays different roles.       
Muscle cell development under 3D culture conditions was also studied. 3D culture 
mimics the tissue environment and hence is known to be a comfortable niche for cells to 
grow. Muscle cells were allowed to differentiate for 10 days under 3D culture condition. 
After which RNA seq was performed. In order to understand the influence of culture 
conditions, we compared RNA seq results of 2D and 3D cultured myotubes. In order to 
see if 3D can mimic skeletal muscle tissue, we compared the RNA seq results of 3D 
cultured myotubes with adult human skeletal muscle tissue. This experiment showed that 
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when cells are cultured under 3D conditions they show immune response by upregulation 
of myokines and Interleukin genes. 3D cultured myotubes showed greater similarity to 
adult skeletal muscle compared to 2D cultured myotubes. As mentioned earlier, adult 
muscle tissue showed upregulation of chemokines, interleukins and major 
histocompatibility genes. This is an indication that 3D culture provides cells with more 
comfortable environment as compared to 2D culture and their transcriptome shifts more 
towards the skeletal muscle tissue state.  
Muscle is known for its remarkable plasticity. Lastly I studied the effect of mechanical 
stretch on molecular events during differentiation process. Uniaxial stretch of cells early 
in differentiation was performed continuously for 30 minutes. The cells were either used 
for RNA seq analysis immediately after stretching or were left for 40h into differentiation 
to study the long term effect of stretch. Immmediately after stretch interleukin, chemokine 
and myokine genes were upregulated but that effect was transient as after 40h of stretch 
these genes were prominently down regulated. Stretching caused a higher population of 
myosin gene expression compared to non-stretched cells. So the finding from the 
experiment was immunogenic response enhancement as a quick response to stretch and 
muscle specific genes upregulation over a course of time post stretch. 
Immunofluorescence showed upregulation of myosin light chain after stretching. Muscle 
cells seemed to have developed a power of resistance and hence a quick differentiation.      
During my PhD, I have tried to develop a comprehensive understanding of muscle 
transcriptome during various developmental stages, miRNA regulation inferred from 
miRNA over expression and Ago2-RIP experiments, effect of culture conditions and 
finally response to mechanical stretch.                  
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Table S2-1A: GO terms of biological processes for gene differentially upregulated in myotubes. 
The number of genes belonging to each term (gene count), enrichment (p-value) and false 
discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-1B: GO terms of cellular compartments for gene differentially upregulated in 
myotubes. The number of genes belonging to each term (gene count), enrichment (p-value) and 
false discovery rate (benjamini value) are shown in the corresponding columns. 
 
 
 
 
 
 
 
 
 
 
 
Table S2-2A: GO terms of biological processes for gene differentially down-regulated in 
myotubes. The number of genes belonging to each term (gene count), enrichment (p-value) and 
false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-2B: GO terms of cellular compartments for gene differentially down-regulated in 
myotubes. The number of genes belonging to each term (gene count), enrichment (p-value) and 
false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-3A: GO terms of biological processes for gene differentially up-regulated in skeletal 
muscle tissue. The number of genes belonging to each term (gene count), enrichment (p-value) 
and false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-3B: GO terms of cellular compartments for gene differentially up-regulated in 
skeletal muscle tissue. The number of genes belonging to each term (gene count), enrichment (p-
value) and false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-4A: GO terms of biological processes for gene differentially down-regulated in 
skeletal muscle tissue. The number of genes belonging to each term (gene count), enrichment (p-
value) and false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-4B: GO terms of cellular compartments for gene differentially down-regulated in 
skeletal muscle tissue. The number of genes belonging to each term (gene count), enrichment (p-
value) and false discovery rate (benjamini value) are shown in the corresponding columns. 
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Table S2-5: Genes up regulated ≥ 5log2 FC in myotubes as compared to myoblasts. The table 
shows the gene names, their description, corresponding log2 fold change and P value. Fold 
change = value describing the average level of increase or decrease in gene expression. 
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Table S2-6: Genes up regulated ≥ 7log2 FC in Skeletal muscle as compared to myotubes. The 
table shows the gene names, their description, corresponding log2 fold change and P value. Fold 
change = value describing the average level of increase or decrease in gene expression. 
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Table S2-7: Protein families and their member genes found upregulated in myotubes. Gene 
names, their description, corresponding log2 fold change and P Value are shown. Fold change = 
value describing the average level of increase or decrease in gene expression.  
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Table S2-8: Protein families and their member genes found upregulated in Skeletal muscle 
tissue. Gene names, their description, corresponding log2 fold change and P Values are shown. 
Fold change = value describing the average level of increase or decrease in gene expression.   
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Table S2-9: List of miRNA differentially upregulated in human skeletal muscle. List has been 
arranged in a descending order of log Fold Change (log 2 FC). Corresponding logCPM and P-
values are also shown. Fold change = value describing the average level of increase or decrease 
in gene expression.     
 
 
 
 
 
 
 
 
 
 
  
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
143 
 
Table S2-10: List of miRNA differentially down regulated in human skeletal muscle. List has 
been arranged in a ascending order of log Fold Change (log 2 FC). Corresponding logCPM and 
P-values are also shown. Fold change = value describing the average level of increase or 
decrease in gene expression. 
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Table S2-11: Genes found enriched with Ago2 pull down in myoblasts but which are under 
expressed in myoblasts. 
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Table S2-12: Genes found enriched with Ago2 pull down in myoblasts but which are under 
expressed in myotubes 
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Table S2-13: GO terms of Biological processes for genes enriched with Ago2 pull down in 
myoblasts but which are under expressed in myoblasts. The number of genes belonging to each 
term (gene count), enrichment (p-value) and false discovery rate (benjamini value) are shown in 
the corresponding columns. 
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Table S2-14: GO terms of Biological processes for genes enriched with Ago2 pull down in 
myoblasts but which are under expressed in myotubes. The number of genes belonging to each 
term (gene count), enrichment (p-value) and false discovery rate (benjamini value) are shown in 
the corresponding columns. 
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Table S3-1: List of genes influenced by hsa-miR-139 over expression. Genes over and under 
expressed after 12 and 24 hours of miRNA over expression have been listed.   
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Table S3-2: List of genes influenced by hsa-miR-532-5p over expression. Genes over and under 
expressed after 12 and 24 hours of miRNA over expression have been listed.   
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Table S3-3: List of genes 
influenced by hsa-miR-660-
5p over expression. Genes 
over and under expressed 
after 24 hours of miRNA over 
expression have been listed.   
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Table S3-4: List of genes influenced by hsa-miR-92a-3p over expression. Genes over and under 
expressed after 12 and 24 hours of miRNA over expression have been listed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S3-5: List of genes influenced by hsa-miR-206 over expression. Genes over and 
under expressed after 12 and 24 hours of miRNA over expression have been listed. 
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Table S3-6: Enriched Biological process terms for has-miR-139-5p. (12H over expresses – 
genes over expressed after 12 hours of miRNA transfection, 24H Over expressed - genes over 
expressed after 24 hours of miRNA transfection, 24H under expressed – genes under expressed 
after 24hours).  
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Table S3-7: Enriched Biological process terms for has-miR-532-5p. (12H over expresses – 
genes over expressed after 12 hours of miRNA transfection, 24H Over expressed - genes over 
expressed after 24 hours of miRNA transfection, 24H under expressed – genes under expressed 
after 24hours). 
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Table S3-8: Enriched Biological process terms for has-miR-660-5p. (24H Over expressed - 
genes over expressed after 24 hours of miRNA transfection, 24H under expressed – genes under 
expressed after 24hours). 
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Table S3-9: Enriched Biological process terms for has-miR-92a-3p. (24H Over expressed - 
genes over expressed after 24 hours of miRNA transfection, 24H under expressed – genes under 
expressed after 24hours). 
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Table S3-10: Enriched Biological process terms for has-miR-206. (12H over expressed - genes 
over expressed after 12 hours of miRNA transfection, 12H Under expressed - genes under 
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expressed after 12hours, 24H Over expressed - genes over expressed after 24 hours of miRNA 
transfection, 24H under expressed – genes under expressed after 24hours). 
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Table S4-1A: Enriched GO terms for genes upregulated in 3D cultured myotubes 
compared to 2D cultured myotubes. Terms for Biological processes, Cellular 
compartments and Molecular functions are shown with %age of genes belonging to each 
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category along with respective P values. The analysis was performed using DAVID 
online software.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S4-1B: Enriched GO terms for genes down-regulated in 3D cultured myotubes 
compared to 2D cultures myotubes. Terms for Biological processes, Cellular 
compartments and Molecular functions are shown with %age of genes belonging to each 
category along with respective P values. The analysis was performed using DAVID 
online software.    
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Table S4-2A: Enriched GO terms for genes up-regulated in Skeletal muscle compared 
to 3D cultured myotubes. Terms for Biological processes, Cellular compartments and 
Molecular functions are shown with %age of genes belonging to each category along 
with respective P values. The analysis was performed using DAVID online software.    
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Table S4-2B: Enriched GO terms for genes down-regulated in Skeletal muscle 
compared to 3D cultured myotubes. Terms for Biological processes, Cellular 
compartments and Molecular functions are shown with %age of genes belonging to each 
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category along with respective P values. The analysis was performed using DAVID 
online software.   
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Table S4-3A: Enriched GO terms for genes up-regulated in Skeletal muscle compared 
to 2D cultured myotubes. Terms for Biological processes, Cellular compartments and 
Molecular functions are shown with %age of genes belonging to each category along 
with respective P values. The analysis was performed using DAVID online software.   
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Table S4-3B: Enriched GO terms for genes down-regulated in Skeletal muscle 
compared to 2D cultured myotubes. Terms for Biological processes, Cellular 
compartments and Molecular functions are shown with %age of genes belonging to each 
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category along with respective P values. The analysis was performed using DAVID 
online software.   
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Table S4-4A: Enriched GO terms for genes up-regulated in 2D cultured myotubes 
compared to myoblasts. Terms for Biological processes, Cellular compartments and 
Molecular functions are shown with %age of genes belonging to each category along 
with respective P values. The analysis was performed using DAVID online software.   
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Table S4-4B: Enriched GO terms for genes down-regulated in 2D cultured myotubes 
compared to myoblasts. Terms for Biological processes, Cellular compartments and 
Molecular functions are shown with %age of genes belonging to each category along 
with respective P values. The analysis was performed using DAVID online software.   
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Table S5-1: List of genes differentially upregulated after 3h of stretch and also after 65 hours of
differentiation without any stretching. The fold change is very similar for both the conditions.
Genes which had higher fold change after 65 hours of differentiation compared to 3h post stretch
have been highlighted in yellow.
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Table S5-2A: Biological process terms for gene differentially up regulated after 3h of 
stretch compared to control. 
 
 
 
 
 
 
 
 
 
Table S5-2B: Biological process terms for gene differentially down regulated after 3h 
of stretch compared to control. 
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Table S5-3A: Biological process terms for gene differentially up regulated after 40h of 
stretch compared to control. 
 
 
 
 
 
 
 
 
 
 
 
 
Table S5-3B: Biological process terms for gene differentially down regulated after 40h 
of stretch compared to control. 
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Table S5-4A: Biological process terms for gene differentially up regulated after 40h of 
stretch compared to 3h post stretch. 
 
 
 
 
 
 
 
 
 
 
 
Table S5-4B: Biological process terms for gene differentially down regulated after 40h 
of stretch compared to 3h post stretch. 
 
 
 
 
 
Table S5-5: Genes differentially  up regulated (>2x fold) after 3h of stretch
compared to control.
177
Table  S5-6:  Genes  differentially  up  regulated  (>2x  fold) after  40h  of  stretch
compared to control.
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